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1 Motivation 
Living organisms are constantly exposed to potentially harmful pathogenes (Reddy 2004). 
Evolutionary old endogenous peptides act as a first line defence. They are ubiquitous among 
all eukaryots and are one of the most important components of their innate immunity 
(Kamysz 2003). These antimicrobial peptides (AMPs) usually consist of 10 to 50 amino acids 
and exhibit an amphipathic spatial distribution of polar (usually cationic) and hydrophobic 
residues in their secondary structure. AMPs are assumed to interact with membranes of 
invaders according to their amphipathicity, selecting for example the negatively charged 
lipids of bacteria, and permeabilize their cellular membranes. 
Such AMPs are promising compounds for the development of new therapeutics to 
treat the growing world problem of microbial resistance against conventional antibiotics. In 
particular, these AMPs have the potential not to be affected by the bacterial resistence 
mechanism (Otvos 2005; Reddy 2004). To modulate the activity of these AMPs in order to 
enhance their selectivity against bacteria, knowledge of their mechanism of action is crucial. 
The ?-helical peptides PGLa and magainin 2 from the African clawed frog Xenopus 
laevis show significant bactericidal, but low hemolytic activity (Soravia 1988). Synergy in 
action between these two peptides has been demonstrated (Westerhoff 1995). For each 
peptide separately and together as a synergetic pair, toroidal pore formation is proposed as an 
explanation of the permeabilizing activity. By solid state NMR spectroscopy, PGLa has been 
shown to adopt different alignment states in synthetic lipid bilayers, dependent on peptide 
concentration (Strandberg 2006; Glaser 2005) and presence of equimolar quantity of 
magainin 2 (Tremouilhac 2006a). These results were used to explain the effects of PGLa 
structurally. 
Do these alignment states of PGLa (S, T and I) only occure in synthetic lipid bilayers 
or can they be identified in cell membranes of bacteria and eukaryots? How does the 
complexity of real biomembranes in terms of composition and thus phase behaviour influence 
the peptide alignment? Can real biomembranes be employed for solid state NMR 
investigations of that kind at all? To answer these fundamental questions for future 
investigations towards a clarification of the situation in vivo, the present study is a desicive 
contribution. 
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2 Theoretical background 
2.1 Biological membranes 
2.1.1 Functions 
The cell is the fundamental unit of life for all organisms. The ability to regulate and 
coordinate vital biochemical processes is strictly bound to a cell. The function of a cell in turn 
is essentially connected to the occurrence and structure of biological membranes. In cells 
different types of membranes exist. All cells possess a cytoplasmic membrane that spatially 
defines the cell. The cytoplasmic membrane acts as a selective barrier for substances, 
separating the outside and the inside of the cell. It enables the cell to maintain a highly 
ordered chemical system. In eukaryotic cells additional intracellular membranes define 
compartments of specific function, separating reaction processes and maintaining defined 
physical and chemical environments. Membranes regulate the distribution of substances, 
carry enzymes for chemical reactions and energy conversions, and are involved in signal 
transductions and in recognition processes (Voet 2002; Alberts 2004; Nultsch 1996). 
2.1.2 Composition 
Despite their various functions, biological membranes possess a common structure principle 
(Voet 2002; Alberts 2004; Nultsch 1996). They are basically lamellar bilayers made up 
mainly of lipids and proteins. Lipids are a class of bio-amphiphiles that self-assemble in 
aqueous environments with their hydrophilic polar head groups directed to the surrounding 
medium and their hydrophobic tails forming the interior of the structure. Lipid bilayers of 
cells are usually 6 to 10 nm thick, depending on the length of the hydrophobic tails. 
According to the currently accepted fluid mosaic model (Singer 1972) the lipid bilayer of a 
membrane forms the fluid matrix in which proteins are either integrally or unilaterally 
embedded, or to which they are extrinsically associated. From a reductionist point of view the 
structural basis for each membrane is lipids forming fluid bilayers (Katsaras 2001). 
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Figure 2.1 The Nicholson-Singer “fluid mosaic model”. It is the standard 
conceptualization of membrane architecture. Lipids self-assemble to form bilayers as 
a matrix in which proteins are embedded. 
 
Membranes differ significantly in their lipid composition as well as in their protein/lipid ratio 
(Evans 1991; Graham 1998; Hanke 1997). The exact composition of a biological membrane 
depends strongly on its origin, i.e. the organism, the organ or tissue, the type of cell and the 
type of membrane in a particular cell. Among the various lipid classes in biological 
membranes the most abundant are glycerophospholipids and sphingolipids (glycolipids) 
(Stryer 1999). Table 2.1 and Table 2.2 show examples for the variation in cytoplasmic 
membrane composition. 
 
Table 2.1 Protein and lipid content of different cytoplasmic membranes as percentage of dry weight 
[% dw]. (Graham 1998; Hanke 1997; Afonin 2003a) 
 
Source Protein Lipid 
Bacillus (Gram-positive) 75 25 
Micrococcus (Gram-positive) 70 30 
Escherichia coli (Gram-negative) 75 25 
Amoeba (Protozoa/Eukaryot) 54 42 
Erythrocyte (Eukaryot) 49 44 
Hepatocyte (Eukaryot) 50 50 
Enterocyte (Eukaryot) 85 15 
Myelin cell (Eukaryot) 20 80 
 
Typically, the cytoplasmic membrane of prokaryots (Bacteria and Archaea) has a higher 
protein content compared to eukaryots (Eukarya). This is due to the fact that physiological 
processes, which are distributed over several compartments and membranes in eukaryots, e.g. 
the endoplasmatic reticulum, mitochondria or plastids, take place at the single membrane in 
prokaryots. Eukaryotic cell membranes typically contain sterols, e.g. cholesterol in animals 
and ergosterol in plants, but bacterial cell membranes do not. Bacterial membranes have a 
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higher content of glycerophospholipids, but only traces of glycolipids, which appear to be 
ubiquitous in the outer layer of animal cell membranes. 
 
Table 2.2 Lipid composition of cytoplasmic membranes from human erythrocytes and bacterial 
protoplasts [% dw]. (Evans 1991) 
 
Source Phospholipids Glycolipids Cholesterol 
Human erythrocyte 61 11 22 
Bacterial protoplast 80 – 90 traces 0 
 
Lipid head groups determine the charge of a membrane. Anionic phosphatidylglycerol and 
net uncharged phosphatidylethanolamin make up the highest percentage of 
glycerophospholipids in bacterial cell membranes. Animal cell membranes characteristically 
possess high amounts of net uncharged phosphatidylcholine. Typical phospholipids of 
cytoplasmic membranes are depicted in Figure 2.2. 
 
Figure 2.2 Typical phospholipids of cytoplasmic membranes and their charge at 
physiological conditions. R=acyl chains 
 
The composition of hydrophobic acyl chains of phospholipids in biomembranes shows a 
significant diversity (Voet 2002; Yawata 2003; Denich 2003). Animal cell membranes 
contain high amounts of unsaturated fatty acids with up to 6 double bonds. Acyl chains are 
usually 16 to 24 carbon atoms in length, most common are 16 and 18 carbon atoms. Bacterial 
cell membranes contain only a low degree of unsaturated fatty acids, but are enriched in 
polyunsaturated ones. Their acyl chains are typically 12 to 24 carbon atoms in length, most 
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commonly 14 to 20. Additionally, Gram-positive bacteria, like Bacillus or Micrococcus, often 
possess unusual acyl chains like branched or cyclopropanated ones. Bacteria are known to 
adapt their cytoplasmic membrane lipid composition to the environmental conditions, like 
temperature, medium composition and the growth phase of a microbial culture. Modification 
of acyl chains or head group alters the packing of lipids within the bilayer and thereby its 
fluidity. 
2.1.3 Asymmetry 
Constituents of biological membranes are usually not distributed regularly, but exhibit lateral 
as well as transversal asymmetry. 
 
Biological membranes contain a variety of regions containing specific proteins and lipids 
assembled to carry out specialized functions. These domains of distinct composition vary 
greatly in size as well as in life span (Tamm 2005; Somerharju 1999; Welby 1996; Lommerse 
2004; Subczynski 2000). 
 Apical membranes of epithelial cells, cell-surface or cell-cell adhesion domains are 
among the largest and most stable cell membrane compartments (Tamm 2005; Subczynski 
2000). The desmosome, a cellular organelle shared by two adhering cells, can be as large as 
10 ?m in diameter and the lifetime of the assembly may be longer than the doubling time of 
the cell in the range of hours. 
The cytoskeleton contributes to partitioning of a cell membrane into compartments of 
30 to 230 nm in size (Tamm 2005; Lommerse 2004; Voet 2002). The part of the cytoskeleton 
linked to the membrane by actin-associated proteins is actually considered part of the cell 
membrane. The skeleton forms a diffusion barrier for integral proteins throughout the cell 
membrane (“fence“). Other integral proteins can be anchored to the skeleton (“pickets“) and 
thereby effectively confine virtually all membrane components, even phospholipids in the 
outer layer. 
“Raft domains“ are transient and highly dynamic microdomains of sphingolipids and 
cholesterol (Tamm 2005; Voet 2002; Alberts 2004). They represent a time-dependent phase 
separation in the fluid lipid bilayer with their size varying in the range of nanometers. They 
serve to accumulate and organize specific proteins for subsequent vesicle transport or signal 
transduction processes, for instance specific receptors like GPI-anchored receptors (glycosyl-
phosphatidylinositol), or cytoplasmic signaling molecules, anchored to the cytoplasmic layer 
of the cell membrane via saturated alkyl chains. 
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Oligomers of proteins, like dimers of G-protein-coupled proteins, or proteins 
specifically interacting with surrounding lipids via polar head groups or hydrophobic acyl 
chains contribute to the heterogeneous distribution of membrane constituent on the smallest 
scale (Subczynski 2000; Voet 2002). 
 
Transbilayer lipid asymmetry has been observed in Bacteria and Eukarya, in cytoplasmic and 
intracellular membranes (Sandra 1978; Herbette 1984). It is actively established and 
maintained via ATP-dependent transbilayer lipid transport. In Bacteria, membrane lipids play 
an essential metabolic function, as they are employed as transporters for components in the 
synthesis of polymers outside the cytoplasmic membrane, like peptidoglycan (Schlegel 1992) 
or lipomannan (Pakkiri 2004; 2.1.7). In erythrocytes, improved membrane mechanical 
stability is achieved by transbilayer lipid asymmetry and interaction of phosphatidylserine 
with the cytoskeleton (Manno 2002). The asymmetric distribution of lipids in human 
erythrocyte cell membranes is shown in Table 2.3. 
 
Table 2.3 Asymmetric distribution of lipids in thee inner and outer leaflet of human erythrocyte cell 
membranes [% dw]. (Graham 1998) 
 
Type of lipid Inner leaflet Outer leaflet 
Sphingomyelin 17 83 
Phosphatidylcholine 26 74 
Phosphatidylethanolamine 77 23 
Phosphatidylserine 95 < 5 
Glycolipids < 5 95 
 
Due to the heterogeneous composition and the irregular distribution of constituents, real 
biomembranes cannot be described as a homogeneous system with bulk phase physical 
properties (Welby 1996). 
2.1.4 Lipid polymorphism 
The ratio between the cross-sectional area of a lipid head group and its acyl chain determines 
its overall molecular shape and classifies it as bilayer or non-bilayer forming lipid. Depending 
on the molecular shape, the supramolecular structure formed in solution by an isolated type of 
lipid shows a characteristic morphology (polymorphism) (Cullis 1986, Seddon 1990; Katsaras 
2001). 
 
 7
 
Figure 2.3 Molecular shapes of lipids and respective 
structures of lipid assemblies in aqueous solution. A bilayer 
can be formed by mixtures of cone shaped and inverted cone 
shaped lipids (complementary effect). (See text for a further 
specification of the phases exhibited by non-bilayer forming 
lipids either in water (type I) or in oil (type II).) 
 
Bilayer forming lipids possess overall cylindrical molecular shape and in aqueous solution, 
i.e. oil-in-water (type I), result in a stable lamellar (L) bilayer conformation (LI phase). Non-
bilayer forming lipids possess conical overall molecular shape with either their head group or 
acyl chains having a bigger cross-sectional area. Non-bilayer forming lipids in solution 
assemble to micellar (M) or hexagonal (H) structures. The inverted hexagonal phase (HII) 
(water-in-oil) represents laterally stacked cylinders, while the hexagonal phase (HI) (oil-in-
water) can be present as individual cylindrical micelles. PE is abundant in cell membranes of 
eukaryots and Gram-negative bacteria, and is an example of a lipid that can spontaneously 
form the inverted hexagonal phase (Seddon 1990). 
Within the lamellar phase, several temperature-dependent (thermotropic) phases are 
discriminated. Two important types of lamellar phase are the gel phase (L?) and the fluid 
phase (L?). L? is characterized by highly ordered all-trans acyl chains, which are tilted with 
regard to the membrane normal. The lateral diffusion of lipids here is relatively slow. Upon 
an increase in temperature above a melting point (the transition temperature Tm), order and 
packing of acyl chains is reduced and mobility increased. Acyl chains are present in cis-
conformation. This state is the fluid lamellar phase L?. The volume of the hydrophobic core is 
increased, and the bilayer thickness is reduced, compared to L?. Many inter-related factors 
control membrane fluidity and thus the value of Tm. It is primarily related to lipid packing 
within the membrane. Lipid packing is determined by shape, which in turn is generally 
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determined by the balance of attractive forces between the acyl chains due to the hydrophobic 
effect and the preference of the hydrophilic head groups to associate with water. A higher 
degree of acyl chain unsaturation results in higher fluidity and lower Tm. Shorter acyl chains, 
on the other hand, allow for higher ordering of lipids and result in less fluidity and higher Tm. 
However, there are other factors which may affect membrane packing of lipids, such as water, 
protein and carbohydrate content. Temperature, pH, presence of cations or ionic strength will 
also affect packing of phospholipids (Denich 2003). 
The biologically relevant lipid phase is the fully hydrated high-temperature fluid state 
L? (Katsaras 2001; Denich 2003). The local presence of non-bilayer forming lipids, however, 
which modify many of the properties of the bilayer, like thickness, permeability and 
deformability, appears to be of fundamental relevance for many processes taking place in, on, 
or through biomembranes. Modification of the properties of the lipid matrix has been shown 
to affect the function and activity of membrane proteins, for instance of mitochondrial 
proteins, of Ca-ATPase or of the lactose permease of Escherichia coli (Seddon 1990; Zhang 
2000). 
Under normal physiological conditions, the majority of phospholipids in the bacterial 
membrane are bilayer forming lipids in the lamellar fluid phase L?. Bacterial cytoplasmic 
membranes can compensate for the alteratin of growth conditions by homeophasic adaptation, 
for instance by adjustment of lipid composition, so that the membrane can remain in the fluid 
phase even as the environment changes. On the other hand, Escherichia coli and 
Acholeplasma laidlawii have been shown to tolerate a wide range of fluidities. Up to 50% and 
80 to 90% of their lipids, respectively, may be in the gel phase without affecting their growth 
(Denich 2003). 
Sterols are essential constituents of eukaryotic membranes, with cholesterol being the 
most common one in animal membranes (Katsaras 2001; Voet 2002). On the one hand, the 
rigid sterol system reduces fluidity of membranes as it inhibits the mobility of acyl chains 
upon increase in temperature. On the other hand, sterols inhibit ordering of acyl chains upon 
decrease of temperature, thereby broadening the phase transition. Temperature variations 
would otherwise alter the thickness of the membrane dramatically. 
2.1.5 Extramembraneous structures 
Bacteria usually possess a rigid cell wall outside the cell membrane, counterbalancing the 
turgor pressure and protecting the cell from osmotic lysis. Cell membrane plus cell wall are 
referred to as the cell envelope. The cell wall consists of peptidoglycan, a heteropolymere, in 
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which linear chains of alternating N-acetylglucosamine and N-actylmureic acid are cross-
linked by group- and strainspecific, often unusual, amino acids (Madigan 2001; Voet 2002). 
 
 
Figure 2.4 The cell envelope of Gram-negative (left) and Gram- positive bacteria (right). 
(Modified from Baron 1991) 
 
In Gram-positive bacteria the cell wall consists of multiple layers together making up about 
25 nm in thickness. Characteristic for Gram-positive bacteria is the occurrence of 
extracellular anionic polymers (Neuhaus 2003; Sutcliffe 1991; Kennedy 1974). Typically 
these are teichoic acids (TA), contributing to the cell wall mass with up to 10 %. They are 
phosphorus-containing polymers with 16 to 40 units of ribitol or glycerol and can be D-
adenylated and/or glycosylated. TAs are usually covalently bound to the peptidoglycan (wall 
teichoic acids – WTA) or are associated with the membrane, anchored to a glycolipid 
(lipoteichoic acids – LTA). They possess cation-binding capabilities and are involved in 
maintaining metal cation homeostasis, thus may play a key role in the osmotic stability of the 
cell. They assist in the trafficking of ions, nutrients, proteins, and antibiotics. They can also 
direct enzymes which function on the cell periphery to the sites of cell wall biosynthesis, like 
autolytic enzymes. Occurring in the fimbriae on the outside of the cell they can be involved in 
adhesion, for instance to epithelial cells allowing colonization of the throat, e.g. by the group 
A Streptococcus. 
Not all Gram-positive bacteria possess conventional LTA and WTA. Those that lack 
these polymers generally have functionally analog polyanions. The first Gram-positive 
bacterium found to lack TA was Micrococcus luteus (formerly M. lysodeikticus) (Sutcliffe 
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1991; Owen 1975). M. luteus possesses lipomannan, a polymer of mannosyl residues being 
esterified with succinyl groups to approximately 25 %. 
 
 
Figure 2.5 Structure of lipomannan of M. 
luteus. Mannose units (n=52-70) are 
succinicated to approximately 25 % (Powell 
1975) 
 
In Gram-negative bacteria the thickness of the cell wall is about 3 nm. The cell wall is located 
in the extended periplasmatic space between the cell membrane (inner membrane) and an 
additional complex outer membrane. The outer leaflet of the outer membrane contains mostly 
lipopolysacccharides (LPS). LPS consist of the Lipid A and an oligosaccharide component, 
which is highly specific for individual bacterial groups. LPS appear to render bacteria 
resistant to an attack of leucocytes in a host, as long as antibodies are not involved. Of 
biological relevance is the endotoxic activity of LPS in animals upon bacterial lysis (Voet 
2002; Schlegel 1992). 
Contrary to other Eukarya, animal cells lack cell walls. However, animal cell 
membranes possess further structures extrinsic to the lipid bilayer of the cytoplasmic 
membrane. Virtually all cells possess a highly developed glycocalyx (Voet 2002). This is a 
densely packed, highly mobile diffuse layer of heterogeneous composition, consisting of 
oligosaccharides bound to lipids in the outer layer of the membrane and to the extracellular 
site of integral proteins. The layer can be up to 140 nm in thickness. The glycocalyx is, in 
general, involved in intercellular communication and recognition processes. 
The boundary of a cell usually goes beyond the plain structure of a lipid bilayer with 
embedded proteins. These extracellular structures provide initial sites of interaction or 
themselves are potential targets for antimicrobial peptides (Papo 2003). 
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2.1.6 The cell membrane of human erythrocytes 
Erythrocytes (Figure 2.6) are probably the best-established cell system and the common 
model for eukaryotic cell membranes. First, they are of clinical interest. Second, their 
membranes are comparatively easy to isolate. They occur as separate, highly differentiated 
cells and when they are released into the blood stream, they no longer contain any organelles 
nor nucleic acids. They are highly specialized for the transport of O2 and CO2, being filled 
almost entirely with hemoglobin (90 % of their dry weight) (Begemann 1993). 
 
 
Figure 2.6 Intact human erythrocytes. Undiluted 
suspension from a blood bag. 
 
The protein to lipid ratio of their membrane is about equal (Table 2.1). 60 to 80 % of their 
membrane lipids are phospholipids, up to 25 % cholesterol and up to 10 % glycolipids (Table 
2.2) (Graham 1998; Evans 1991). 
The erythrocyte membrane is transversally asymmetric (2.1.3), containing the 
zwitterionic net neutral SM and PC predominantly in the outer membrane leaflet of the 
bilayer. Zwitterionic PE and the net negatively charged PS are present predominantly in the 
inner bilayer leaflet. Glycolipids are almost entirely (95 %) located in the outer leaflet. 
Phosphatidylinositol (PI) is only present in low amounts and entirely located in the inner 
leaflet (Begemann 1993; Voet 2002; Graham 1998). 
The erythrocyte membrane contains a wide variety of proteins. The number of protein 
molecules at the membrane interior outnumbers that of the exterior (Zwaal 1976). 
Glycoproteins are arranged such, that their hydrocarbon chains point outwards (2.1.5). 
 
For the preparation of erythrocyte membranes (ghosts), the cells can be exposed to the 
hypotonic medium directly. Water molecules follow the gradient of solutes (hemoglobin) 
inside the cell and cause it to swell. In NaCl solution, lysis begins below 0,5 % (Baake 1994; 
Begemann1993). Increasing its volume by a factor of 1,5, the cell becomes leaky and solutes 
equilibrate across the cytoplasmic membrane (Schwoch 1973). The membrane reseals for 
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larger molecules like hemoglobin, but stays permeable for smaller compounds like ions 
(Baake 1994; Begemann1993; Schwoch 1973). Serveral types of ghosts have been described, 
depending on their purity with regard to their residual hemoglobin and their permeability 
(Dodge 1963; Ting-Beall 1981). Factors like osmolarity, pH and temperature of lysis solution 
and ratio of the lysis solution to erythrocyte volume influence properies of ghosts and have 
been systematically investigated (Dodge 1963). 
2.1.7 The cell membrane of Micrococcus luteus 
Micrococcus luteus (Figure 2.7) is a spherical Gram-positive bacterium. It forms yellow 
pigmented colonies on agar plates, is strictly aerobic, non-sporulating and arranged in small 
clusters (tetrades). It can be isolated from soil, water and dust particles, is a regular inhabitant 
of the human skin and various mucosae and is involved in food rotting (Madigan 2001; 
Schlegel 1992). M. luteus is generally considered to be non-pathogenic, however, it may 
cause skin infections in immunocompromised persons and even rare cases of prosthetic valve 
endocarditis are described for this bacterium (Seifert 1995; Durst 1991). Therefore, M. luteus 
must be considered a nosocomial pathogen or opportunist. 
 
 
Figure 2.7 Micrococcus luteus ATCC 4698. Cells 
arranged as a tetrade. 
 
The ratio of protein to lipid in the cell membrane of M. luteus is about 7 to 3 (Table 2.1). The 
lipids comprise up to 70 % negatively charged PG predominantly located in the outer layer 
and about 30 % dimannosyldiacylglycerol (DMDG) symmetrically distributed between both 
leaflets (de Bony 1989; Graham 1998). 
However, cell cycle-dependent changes in the transbilayer distribution of the two 
major lipids PG and DMDG in cell membranes of M. luteus could be observed by application 
of synchronized cultures (Welby 1996). The distribution shows least heterogenity during cell 
growth and maximum heterogeneity during cell division. It is proposed, that DMDG together 
with other mannolipids, is involved in the transportation of mannose from the cytoplasm to 
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the external surface of the cytoplasmic membrane and the assembly of lipomannan there 
(Pakkiri 2004). 
M. luteus belongs to the constantly growing group of bacteria known to lack TA. Most 
of them still possess phosphate-containing anionic cell wall components (Neuhaus 2003; 
Sutcliffe 1991). Micrococcal lipomannan (Figure 2.5), however, even lacks phosphate. 
Analytical studies on a highly purified preparation of the lipomannan revealed that it was 
composed of mannose, succinate, fatty acid, and glycerol in a ratio of 50/5/2/1 (Pless 1975). 
 
To prepare cell membranes from M. luteus by osmotic lysis in a similar manner as described 
for erythrocytes, the thick cell wall first needs to be removed by lysozyme. Lysozyme 
hydrolyzes ?(1-4)-linkages between N-acetylmuraic acid and N-acetylglucosamine residues 
in peptidoglycans. The activity of lysozyme is a function of pH and ionic strength, being 
active over a broad range of pH from approximately 5,0 to 9,0 (Banerjee 1973; Banerjee 
1975). M. luteus shows a high sensitivity to lysozyme if grown under appropriate conditions 
(Prasad 1965). Since the sensitivity of bacteria towards lysozyme depends on numerous 
factors (Atrih 1999; Hayashi 1973; Araki 1972), careful conditioning of M. luteus is essential 
for the success of cell wall removal. Resistance to lysozyme increases, for instance, with the 
degree of peptidoglycan cross-linking. This in turn, is influenced by the growth phase, for 
instance, and is markedly increased in the stationary phase. However, in a non-synchronized 
culture, within each growth phase cells at various states of the cell cycle are present, resulting 
in a significant amount of lysozyme-resistant cells. Furthermore, modifications at various 
sites of peptidoglycan are known to reduce the sensitivity to lysozyme, e.g. de-N-acetylation 
or O-acetylation. These, in turn, may depend on the composition of the growth medium. 
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2.2 Antimicrobial peptides (AMPs) 
2.2.1 General properties 
Small cationic amphipathic peptides exhibiting antimicrobial activity are found in virtually all 
organisms throughout the whole phylogenetic tree (Hancock 1999; Epand 1999; Wu 1999). 
These antimicrobial peptides (AMPs) are typically 10 to 50 amino acids in length and possess 
positive charge mainly due to Lys, Arg and His residues clustered on one face of the 
molecule, with hydrophobic residues on the opposing face. Apart from those common 
features, AMPs vary significantly in length, sequences and secondary folds (Huang 2000; 
Matsuzaki 1999; Toke 2005; Papo 2003). Various approachs exist to classify them, one 
grouping them as (a) peptides that form ?-helical structures, (b) peptides rich in cysteine 
residues forming intramolecular disulfide bonds, (c) peptides that form ?-sheets, (d) peptides 
rich in a particular regular amino acid such as His, Arg and Pro and (e) peptides composed of 
rare and modified amino acids (Kamysz 2003; Reddy 2004). 
To date more than 800 have been identified in nature (Bechinger 2006; Hancock 
2006). They are listed in the Antimicrobial Sequences Database at the University of Triest 
http://www.bbcm.univ.trieste.it/~tossi/antimic.html. Representative AMPs with their 
proposed structures in membraneous or membrane-mimicking environments are listed in 
Table 2.4. 
 
Table 2.4 Brief selection of AMPs with their primary sequence, supposed secondary structure and origin. 
 
Peptide Sequence Structure Origin References 
Gramicidin A fVdGAdLAdVVdVWdLWdLWdLWEt ?-helix Aneurinibacillus 
migulanus 
Wallace 2000 
Berditsch 2007 
Gramicidin S cyclo-(VOLdFP)2 ?-sheet 
Aneurinibacillus 
migulanus 
Prenner 2005 
Berditsch 2007 
Cecropin A 
KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQ
ATQIAK-CONH2 
?-helix Hyalophora cecropia Sato 2006 
Melittin GIGAVLKVLTTAGLPLISWIKRKRQQ-CONH2 ?-helix Apis melifera Sato 2006 
Magainin 2 GIGKWLHSAKKFGKAFVGEIMNS ?-helix Xenopus laevis Hara 2001 
Buforin 2 TRSSRAGLQWPVGRVHRLLRK ?-helix Bufo bufo gargarizans Park 2000 
Histatin 5 DSHAKRHHGYKRKFHEKHHSHRGY ?-helix Homo sapiens Helmerhorst 1997 
d – D-enantiomer 
f – Formyl 
Et – Ethanolamine 
O – Ornithine 
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In Eukarya AMPs are typically derived from genetically coded precursors and may undergo 
common post-translational modification. In Bacteria, AMPs may be drastically modified, as 
they may be produced or processed non-ribosomally by multifunctional enzymes. They may 
contain unusual or non-proteinogenic amino acids like Ornithin and D-enantiomers of amino 
acids, or moieties derived from amino acids (Hancock 2006; Hancock 1999; Toke 2005). 
In animals AMPs appear to be key components of the innate immunity and constitute 
a primary defense system against invading microorganisms. They are produced, stored and 
secreted in exposed tissues or synthesized upon stimulation (Matsuzaki 1999; Wu 1999). 
However, the antimicrobial activity of AMPs from mammals is rather weak, and the 
modulation of the immune response by these peptides may be an important factor (Hancock 
2006). 
2.2.2 Targets 
In general, the mechanism of antimicrobial action of AMPs is not very well established and 
remains a matter of controversy. There is, however, a consensus that most AMPs interact with 
the lipid bilayer of cell membranes and possess membrane perturbing and even disrupting 
potential (Reddy 2004; Epand 1999; Wu 1999). The amphipathic structural arrangement of 
AMPs plays an important role in this mechanism as modification of structural parameters like 
peptide helicity, hydrophobicity, hydrophobic moment, peptide charge and the ratio of the 
hydrophobic/hydrophilic domain modulate interaction with and the degree of perturbance of 
membranes (Dathe 1999; Dathe 1996). 
 High amounts of anionic polymers on the cell surface and of anionic phospholipids in 
the cell membranes of bacteria provide a ready explanation for the peptide specificity, as 
cationic AMPs will be preferentially accumulated in the cell wall and bind to negatively 
charged bacterial membranes, in contrast to predominantly zwitterionic amphiphiles in 
mammalian cell membranes (Epand 1999; Hancock 2006; Reddy 2004). Modification of the 
net negative charge of the bacterial cell surface by addition of positively charged residues, 
helps bacteria to avoid being killed by antimicrobial peptides. This can be done for instance 
by esterification of teichoic and lipoteichoic acids with D-Ala, by incorporation of PE into the 
cell membrane or by addition of the cationic amino acid lysine to the negatively charged PG 
as in S. aureus (Pietiainen 2005; Cao 2004; Ganz 2001). 
However, there is uncertainty as to how the membrane perturbation itself is related to  
the antimicrobial activity (Epand 1999). There is not always a simple correlation between the 
charge of a peptide and its antimicrobial activity, nor between its ability to permeabilize 
membranes and its antimicrobial activity (Dathe 1999; Wu 1999). Effects on membranes may 
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simply be the manner by which these peptides enter the cell to reach an alternative target 
(Epand 1999). For instance, buforin 2 (Table 2.4) was demonstrated to kill bacteria by 
binding to nucleic acids (Otvos 2005). It penetrates the membrane, but does not permeabilize 
it. It was found to accumulate in the cytoplasm. In contrast, magainin 2 (Table 2.4 and 
2.2.4.2) remains associated with the inner leaflet of the lipid bilayer of artificial membranes 
after translocation (Park 2000). 
For an increasing number of AMPs, complex activities are shown. On the one hand, 
they appear to have other mechanisms than membrane perturbance to kill bacteria (Reddy 
2004). For instance, it has been hypothesized, that bovine seminalplasmin activates the 
autolysis cascade in bacteria. Another example is PP-39, that has been shown to inhibit 
protein synthesis and to induce degradation of proteins required for DNA synthesis. On the 
other hand, apart from their direct cytotoxic activity, AMPs appear to regulate the innate 
immunity of the host (Mookherjee 2007; Kamysz 2003), selectively enhancing or altering the 
host defence mechanism without targeting the pathogen directly. The above mentioned PP-
39, for example, acts as a chemoattractant for phagocytes. Defensins influence the production 
of cytokines. 
Even in cases when the bacterial cell membrane itself may be the primary target of 
AMPs, secondary effects apart from leakage as the direct cause for cell death, may be 
difficult to evaluate (Pietiainen 2005). The natural membrane-active cationic ?-helical human 
AMP LL-37 from the cathelicidin family is assumed to disrupt membranes by a toroidal pore 
(2.2.3). For Bacillus subtilis, however, a rather complex stress response to LL-37 could be 
shown, including the activation of several signal transduction pathways at a subinhibitory 
concentration. It was hypothized that gene activation was stimulated by the interaction with 
the cell membrane surface and the cell wall, rather than deeper effects inside the membrane. 
The applied amount of an AMPs needs to be considered, as effects at low concentration may 
differ from effects at high concentration, where cell lysis becomes dominant (Kamysz 2003). 
Toxicity against eukaryotic cells can be significant for some AMPs and may pose 
severe difficulties when thinking about a clinical application of AMPs. Hemolytic activity, 
being a direct result of membrane perturbance, seems to be primarily related to hydrophobic 
interactions between AMPs and lipids (Dathe 1999; Toke 2005). 
2.2.3 Modes of interaction with lipid membranes 
The model explaining the membrane-perturbing activity of most AMPs is the Shai-
Matsuzaki-Huang (SMH) model (Zasloff 2002; Huang 2000; Matsuzaki 1999; Shai 1999). 
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This model was initially proposed for magainin 2 describing the formation of transmembrane 
(toroidal) pores. The described stepwise membrane perturbance, however, is applicable on 
most AMPs. 
 In an initial step, AMPs bind to a membrane in the lipid head group region according 
to their amphipatic properties (Figure 2.8 upper). Hydrophilic cationic residues are directed 
towards the surrounding medium, hydrophobic residues are inserted into the core of the 
membrane. This surfacial alignment is supposedly functionally inactive (Matsuzaki 1999; 
Huang 2000). After reaching a threshold concentration, peptide perturbation of the membrane 
occurs. Several complex and controversial mechanisms describe the permeabilizing and 
disrupting effects. Three cooperative mechanisms are illustrated in Figure 2.8 and described 
below. 
 
 
Figure 2.8 The Shai-Matsuzaki-Huang (SMH) model describes the activity of AMPs as a stepwise event. 
First, the AMP binds to the membrane surface. When a threshold concentration is reached, membrane 
perturbance occurs. Three cooperative permeabilization mechanisms are illustrated (see text below). In this 
figure ?-helical AMPs are depicted as cylinders with their hydrophilic (charged) and hydrophobic faces 
coloured in red and blue, respectively. 
 
1.) The carpet mechanism describes the disruption of the membrane at high local 
peptide concentrations (Shai 1999). The presence of negatively charged lipids is important for 
a peptide carpet to form, as they help to reduce the repulsive electrostatic forces between 
positively charged peptides. High local peptide concentrations can be achieved, when cationic 
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peptides phase-separate into domains rich in acidic phospholipids (Bechinger 1999). This 
mechanism is used to describe the mode of action of dermaseptins. 
 2.) The barrel stave or transmembrane helical bundle is the classical picture to 
explain the formation of pores. Above a threshold concentration peptides aggregate and align 
to an inserted state (Shai 2000; Matsuzaki 1999). Discrete openings are proposed to form, 
with the hydrophobic face of the peptide interacting with the non-polar lipid acyl chains and 
the hydrophilic face of the peptide forming the interior of the pore (Toke 2005). This 
mechanism is observed predominantly for peptides where not too many cationic residues will 
accumulate in the highly restricted volume of the pore interior (Bechinger 2006; Bechinger 
1999). Alamethicin is assumed to form this type of pore (Yang 2001). 
 3.) The wormhole- or toroidal pore mechanism is an extension of the transmembrane 
helical bundle. To relieve the bilayer from unfavourable stress induced by the accumulation 
of peptide molecules in the outer leaflet, the layers bend continuously from one membrane 
leaflet to the other like the inside of a doughnut (Toke 2005). Peptides translocate 
stochastically to the inner leaflet (Matsuzaki 1995b; Matsuzaki 1999). Negatively charged 
phospholipid head groups together with positively charged peptide chains line the wall of the 
pore to reduce repulsive interactions due to the high positive charge-density of the peptides 
(Matsuzaki 1996; Bechinger 2006). Such a pore structure was first proposed for melittin and 
magainin (Yang 2001; Tamm 2005) upon the observation that magainin induces rapid lipid 
flip-flop coupled with pore formation (Matsuzaki 1996). Formation of transmembrane pores 
is a transient event. Translocation of peptide from the outer leaflet to the less populated inner 
leaflet reduces membrane stress, slowing down channel formation and leading to a 
deactivation of the pore (Matsuzaki 1995b). The lifetime of a pore is reduced with increasing 
positive charge of the involved peptide (Matsuzaki 1999). 
2.2.4 Antimicrobial peptides used in this study 
Amphibian tissues are an abundant source of bioactive peptides and amines. Many of them 
are strikingly similar or identical to mammalian hormones and neurotransmitters. Several 
such peptides exhibit a broad spectrum of antimicrobial and membrane perturbing activites 
(Dockray 1975; Andreu 1985; Sures 1984; Gibson 1986; Moore 1991; Soravia 1988). 
Two of these peptides are Peptidyl-glycine-leucine-carboxyamide (PGLa) and 
magainin 2 of the South African clawed frog Xenopus laevis, which were employed in this 
study. 
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2.2.4.1 Peptidyl-glycine-leucine-carboxyamide (PGLa) 
Peptidyl-glycine-leucine-carboxyamide (PGLa) is a linear peptide of 21 amino acid residues 
(GMASKAGAIAGKIAKVALKAL-NH2). It is basic, carrys five positive charges (four 
lysines and one charge at the N-terminus) and has a high amount of hydrophobic residues, 
especially alanines. In aqueous solutions it has no well-defined secondary structure, but 
adopts an amphipathic ?-helical structure, demonstrates for the residues 6 to 21, upon binding 
to lipid bilayers (Bechinger 1998; Wieprecht 2000). A helical wheel representation is shown 
in Figure 2.9. 
 
 
Figure 2.9 Helical wheel representations and sequences of 
PGLa and magainin 2. Hydrophobic faces of the helices are 
shown in grey, cationic residues are boxed. PGLa has an 
amidated C-terminus (modified from Tremouilhac 2006a). 
 
PGLa was originally found in the skin secretion of the South African clawed frog Xenopus 
laevis (Hoffmann 1983; Andreu 1985), subsequently also in its gastrointestinal system 
(Moore 1991). Its direct precursor, from which it is produced by proteolytic cleavage, is the 
24 amino acid intermediate PYLa, which originates from a 64 amino acid long parent 
polypeptide. Together with a number of other peptides produced from the xenopsin-, 
caerulein- and PGLa-precursor families, PGLa is stored in the secretory vesicles in the 
granular glands (Gibson 1986; Giovannini 1987). Xenopsin, caerulein and PGLa are assumed 
to derive from genes representing different members of the same gene family (Sures 1984). 
Xenopsin shows similarity to mammalian neurotensin. In the skin, these peptides are secreted 
especially upon stress, suggesting a defensive function (Giovannini 1987), presumably 
against predators, as PGLa was proposed to serve as a permeability factor, that could 
facilitate the uptake of highly active hormones through mucuous membranes and thereby 
 20
make the skin secretion of X. laevis very effective (Andreu 1985). In the stomach, active 
control over bacterial growth was proposed, as X. laevis swallows its prey intact and stores it 
for some time before digestion begins (Moore 1991). 
PGLa exhibits significant broad spectrum antibacterial activity and was shown to 
induce osmotic lysis on several protozoa, but possesses negligible hemolytic activity. It was 
proposed that its mechanism of action could involve the formation of transmembrane 
channels (Soravia 1988). 
PGLa was shown by solid state NMR to undergo a concentration-dependent 
realignment at ambient temperature in fluid phase synthetic lipid bilayers consisting of 
dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylglycerol (DMPG) at 
the lipid molar ratio of 3 to 1 (Glaser 2004; Glaser 2005; Strandberg 2006) (Figure 2.10). 
PGLa was shown to reside in a peripherally-bound surface alignment (S-state) at the low 
peptide to lipid ratio (P/L) of 1/200 and to adopt a tilted alignment (T-state) at a high P/L 
ratio of 1/50. Upon realignment the C-terminus of the helix immerges into the hydrophobic 
core of the lipid bilayer. PGLa in the T-state was suggested to form antiparallel dimers. 
 
 
Figure 2.10 Concentration-dependent realignment of 
PGLa in oriented lipid bilayers (see text). Peptide 
helices are shown as cylinders. Arrows above indicate 
rotational mobility of the peptide around the membrane 
normal. 
 
Factors like lipid head group charge and hydration of a sample were shown to influence the 
process of realignment with regard to the threshold concentration for the S-T transition, but 
not the orientations themselves (Tremouilhac 2006b). 
A transmembrane alignment of PGLa, which is postulated by the toroidal pore model 
as the mechanism of antimicrobial function could not be detected so far. 
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2.2.4.2 Magainin 2 
Magainin 2 is a linear peptide of 23 amino acid residues 
(GIGKFLHSAKKFGKAFVGEIMNS). It is basic, carries five positive charges (four lysines 
and one charge at the N-terminus) and two negative charges (glutamate and the C-terminus). 
Like PGLa it adopts an amphipathic ?-helical structure upon binding to lipid bilayers. A 
helical wheel representation is shown in Figure 2.9. 
Magainin 2 was originally extracted from the ventral skin of the South African clawed 
frog X. laevis following the intriguing observation that despite non-sterile surgical removal of 
ovaries, wounds extremely rarely developed infections (Zasloff 1987). Subsequently it could 
also be found in the secretions of the skin (Giovannini 1987) and like PGLa in the 
gastrointestinal system. The precursor protein of 160 amino acids is cleaved inti one molecule 
of magainin 1 and two molecules of magainin 2. 
 Like PGLa, magainin 2 exhibits significant broad spectrum antimicrobial activity, 
including bactericidal activity and lytic activity on protozoa, but almost no hemolytic activity 
(Soravia 1988; Zasloff 1987). 
Magainin 2 was demonstrated to form weak voltage-dependent anion-selective 
channels (Zasloff 1988; Sitaram 1999). Coupling of lipid flip-flop and peptide translocation 
to the formation and deactivation of these pores was shown. The concept of the toroidal pore 
was proposed for magainin 2 (Ludtke 1996; Matsuzaki 1999; Matsuzaki 1996; Matsuzaki 
1995b). In addition to an orientation of the peptide helix parallel to the membrane surface 
(Bechinger 1993), the formation of water-filled cavities, resembling pores, could be detected 
in aligned membranes at high magainin 2 concentrations (Matsuzaki 1999; Bechinger 2006). 
The activity of magainin 2 was shown to be sensitive to the lipid composition of the bilayer 
(Matsuzaki 1998) preferentially interacting with anionic phospholipids and exhibiting weak 
activity in the presence of sterols (Matsuzaki 1995). Both is in full accordance with selective 
action on bacteria but not on erythrocytes. 
2.2.4.3 Synergistic effects of PGLa and magainin 2 
PGLa and magainin 2 exhibit marked functional synergism in antibacterial activity and 
leakage of synthetic membrane vesicles (Westerhoff 1995), as well as in hemolytic activity. 
Synergism is explained to arise as a result of the formation of parallel heterodimers in 
membrane bilayers (Hara 2001), allowing the formation of pores at a faster rate as either 
peptide, being moderately more stable than pores formed by PGLa alone (Matsuzaki 1998b). 
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 By solid state 2H-NMR spectroscopy, PGLa could indeed be shown to adopt an 
upright alignment (I-state) in the presence of magainin 2 in the 1/1/75/25 molar ratio of 
PGLa/magainin/DMPC/DMPG (Tremhouilhac 2006a) (Figure 2.11). That finding is 
compatible with the above mentioned postulated toroidal pore structure and higher stability of 
the pores could explain the synergistic enhancement in activity. 
 
 
 
Figure 2.11 The recently found insertion of PGLa 
in presence of magainin 2 (in a molar ratio of 1/1) 
(see text). Peptide helices are shown as cylinders, 
PGLa coloured in grey, magainin 2 in green. Arrow 
above PGLa at low P/L ratio indicates rotational 
mobility of peptide along the membrane normal. This 
is absent in the I-state in presence of magainin 2. 
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2.3 Solid state nuclear magnetic resonance (NMR) spectroscopy 
This chapter deals with the fundamentals of nuclear magnetic resonance (NMR) spectroscopy 
in general, the principal concept of solid state NMR and the employment of the CF3-group to 
study peptides in lipid environment (Strandberg 2004b; Ulrich 2004; Bechmann 2000; Dürr 
2005; Duerr 2002; Hoffmann 2000; James 1998; Afonin 2003a). 
2.3.1 Fundamentals of NMR spectroscopy 
NMR employs an intrinsic property of atomic nuclei, their nuclear spin. Only nuclei with 
spin I > 0  are suited for this method. Placing the nuclei in an external magnetic field gives 
rise to different energy for different spin states. Application of electromagnetic radiation in 
the radio frequency (RF) range, enables transitions between different energy states 
(resonance) to be measured, resulting in the NMR spectrum. 
In solid state NMR spectroscopy the orientational dependence of internal interactions, 
i.e. interactions between nuclear spins of a sample, can be detected. In solution these 
interactions are averaged out due to fast isotropic motions of the molecules and cannot be 
observed directly. 
 
The spin of an atomic nucleus is composed of the spins of its protons and neutrons, each 
having a spin I =1/2. The resulting nuclear spin is described by its spin quantum number I , 
being an integer multiple of 1/2. A selection of nuclear isotopes along with their properties is 
shown in Table 2.5. 
 
Table 2.5 A selection of nuclear isotopes and their properties (compiled from references above). 
 
Isotope Spin quantum 
number I 
Gyromagnetic 
ratio ? [T-1s-1] 
Natural 
abundance [%] 
Sensitivity 
(relative to 1H) 
1H ? 2,675?108 99,98 1,0 
2H 1 4,11?107 0,015 0,0096 
12C 0 – 98,9 – 
13C ? 6,73?107 1,1 0,0159 
14N 1 1,93?107 99,6 0,00101 
15N ? -2,71?107 0,36 0,00104 
19F ? 2,517?108 100,0 0,833 
31P ? 1,083?108 100,0 0,0663 
32S 0 – 99,26 – 
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Due to its nuclear spin the nucleus has a magnetic moment µ . This is proportional to the spin 
vector I  and to the gyromagnetic ratio ? , a constant for each nucleus, according to µ = ? I . 
When no magnetic field is present, the magnetic moments of nuclei can be aligned randomly 
in any direction. The energies of all nuclei are identical, i.e. they exhibit Zeeman degeneracy. 
When these nuclei are placed in a magnetic field B0, they exhibit Zeeman splitting, i.e. they 
adopt different discrete energy states proportional to their magnetic moment µ and the applied 
magnetic field (Figure 2.12). The number of possible energy states they can adopt, depends 
on their spin quantum number I. 
 
Figure 2.12 Zeeman splitting for nuclei with I=1/2 results 
in the two different spin states ?  (higher) and ?  (lower). 
?E between the energy levels of both spin states is linearly 
dependent on the external magnetic field B0 and on the 
gyromagnetic ratio ?  of a particular type of nucleus. 
 
Nuclei 31P and 19F with I =1/2 were used in this study. They exhibit two energy states, lower 
? and higher ?. The projection of a nuclear spin magnetic moment along the direction of the 
magnetic field, is either parallel or antiparallel, with the parallel orientation being the lower 
energy state. The extent to which nuclear spins favour the low-energy state over the high-
energy state at equilibrium is described by the Boltzmann equation. 
The slight excess of nuclear spins in the lower energy state at equilibrium results in a 
net magnetic field (vector) of a sample along the direction of the applied magnetic field, i.e. 
the z-axis. That is called the bulk equilibrium magnetization. 
The different energy levels give rise to the NMR spectrum, as the nuclear spins can 
undergo a transition between both energy states upon absorption of electromagnetic radiation 
matching these energy difference (resonance). At magnetic field strengths used in NMR 
experiments, the frequencies necessary to fulfill that condition are in the RF range, i.e. in the 
range of tens to hundreds of MHz. 
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2.3.2 Single-pulse experiment 
In a single-pulse experiment (Figure 2.13) an RF pulse of appropiate frequency and duration 
is applied from the (sample/receiver) coil along the x-axis. That 90°x-pulse rotates the 
magnetization vector M0 away from its equilibrium position along the z-axis around the x-
axis onto the -y-axis. The magnetization vector rotates around the external magnetic field 
vector in the xy-plane at its Lamor frequency ? = ?? B0. The Lamor frequency corresponds to 
the difference between the two energy states and for a given external static magnetic field is 
proportional to the gyromagnetic ratio ?  of a nucleus, hence it is a characteristic for each 
isotope. The rotation of the magnetization vector around the z-axis induces an oscillating 
current in the (sample/receiver) coil along the x-axis, the free induction signal. This is the 
NMR-signal. Relaxation processes cause this x-magnetization to decay away to zero over 
time, returning to equilibrium. The signal is also called free induction decay (FID). Fourier 
transformation converts the time domain signal, the FID, into a frequency domain signal, the 
NMR spectrum. 
 
Figure 2.13 Basic principle of a single-pulse experiment as described in the text. 
 
2.3.3 Spin interactions 
Spin interactions can be grouped into external and internal interactions. External interactions 
are the above described Zeeman interaction with the external static magnetic field B0 and the 
interaction with the applied B1-field (RF). From the above description one should expect the 
same frequency signal for identical isotopes in a particular NMR experiment. However, the 
exact resonance frequency is slightly changed due to several internal interactions of the 
nuclear spins, i.e. due to their environment in the sample. These internal interactions 
modulate the energy states and the transitions between them. That is the main source of the 
information NMR spectroscopy can give, including the local structural information. Internal 
interactions are chemical shielding, J-coupling, dipolar coupling and quadrupolar coupling. 
They depend on the chemical environment of a nucleus. 
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Only two of these essential internal interactions will be used in this work and will be 
described in brief below, i.e. the chemical shielding and the dipolar coupling, resulting in 
shifts and splittings of signals in the spectrum, respectively. 
2.3.3.1 Chemical shielding 
The effective magnetic field that a nucleus encounters depends on its electronic environment, 
as the surrounding electrons may enhance or reduce the applied external magnetic field, by 
generating a secondary magnetic field. Depending on the chemical surrounding, the 
resonance frequency of a nucleus is slightly shifted. Values for the chemical shift are very 
small compared to the Lamor frequency and are given in parts per million (ppm). The 
chemical shift has a time-averaged (isotropic) value in solutions, where molecular tumbling is 
in the range of up to 103 GHz. That results in a particular resonance shift for nuclei in a 
particular type of chemical surrounding, e.g. for a certain chemical group. 
However, the electron distribution around a nucleus is not spherically symmetric, but 
depends on the shape of its molecular orbital. In solids, where the motion of molecules is 
restricted, the chemical shift hence depends on the orientation of a molecule within the 
applied external magnetic field. This effect is called chemical shift anisotropy (CSA). Every 
orientation of a molecule with regard to the magnetic field contributes to the overall spectrum 
by a single line of a particular frequence. 
In a single crystal, all molecules have the same orientation and a single signal is 
obtained, varying with the orientation of the crystal. In a powder, where all orientations of 
molecules are present, the resulting spectrum is called a “powder spectrum”. 
 The orientational dependence (anisotropy) of the chemical shift can be mathematically 
described by a CSA tensor (3 x 3 matrix) and can be visualized as an asymmetric ellipsoid, in 
the most general case with three different main tensor components. Transformed into its own 
principal axes system (PAS) by diagonalization, the three main tensor elements coincide with 
the three coordinate axes of the PAS. The PAS is characteristic for each nucleus in its specific 
chemical environment and the applied external magnetic field is not necessarily aligned along 
the z-axis anymore. A general tensor with three different principal axes is shown in Figure 
2.14. The order of shielding magnitude of the tensor elements is defined as ?11 ?? 22 ?? 33  
with ?11 representing the least shielded element, resulting in the highest field resonance, and 
? 33 the most shielded element, resulting in the lowest field resonance (Figure 2.15, upper 
three pictures). The orientation of the external magnetic field B0 vector in the PAS system is 
described by the angles ?  and ? between B0 and the PAS z-axis, i.e. ? 33 (Figure 2.14). 
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Figure 2.14 Graphical presentation of a CSA tensor with three different principle axes. The tensor 
represents the orientation-dependence of the chemical shielding. The lenght of a vector along B0 from center to 
surface (r) of the ellipsoid defines the frequency in the NMR spectrum. 
 
In an unoriented powder, all orientations of a molecule are present with equal probability. 
However, except for the outermost tensor values, several combinations of the polar angles 
deliver the same values for r, resulting in a characteristic powder pattern or tensor line shape 
(Figure 2.15, lower). 
 
 
Figure 2.15 CSA anisotropy for a tensor with three different principle axes. The tensor ellipsoid (left) is 
depicted aligned with its principal axes along the magnetic field, resulting in the characteristic frequencies right 
upper) of the powder spectrum (right lower), which is the sum of single frequencies of multiple randomly 
aligned tensors in a sample, i.e. molecules with different orientations. 
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In solutions of low viscosity, where the molecules move rapidly along all three axes, the 
electronic environment is averaged out to a spherical distribution, giving an isotropic value 
for the CSA tensor and hence for the chemical shift, as mentioned above, according to 
? ISO = (?11 +? 22 +? 33) /3. 
2.3.3.2 Dipolar coupling 
The magnetic behaviour of a nucleus may be influenced by the dipolar moment of another 
nuclei in the vicinity and vice versa. The NMR transition splits up into two or more lines. 
This interaction through space is called dipolar coupling. The NMR spectrum shows 
respective dipolar splitting of signals. Dipolar couplings can be hetero- and homonuclear. 
The value of the dipolar splitting depends on the distance r between the nuclei and on 
the angle ? between the internuclear connection vector and the applied magnetic field (Figure 
2.16). The dipolar tensor is intrinsically axially symmetric. The secular part of the dipolar 
coupling is described by? SS = ? SS0 (3cos2? ?1) /2 and is expressed in kHz. The absolute value 
of the dipolar coupling is measured. The coupling constant ? SS0  is proportional to 1/r
3 and to 
the magnetic moments of the two nuclei, i.e. it depends on the types of nuclei. 
 
Figure 2.16 The dipolar coupling 
between two nuclear spins depends on 
their distance r and the angle ?  
between the internuclear vector and the 
applied magnetic field. 
 
Like the chemical shift, the dipolar coupling of an unoriented powder sample shows a broad 
distribution of lines in the spectrum, according to all orientations being present. In solution, 
the dipolar coupling is averaged to zero as it does not possess an isotropic component. 
2.3.4 
31
P-NMR as a tool to study phospholipids 
Phospholipids in a membrane environment under physiological conditions can rotate freely 
along their longitudinal axis, but are restricted in their tilt. Hence, the three-component 31P 
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CSA tensor of the phospholipid head group is averaged to an axially symmetric CSA tensor, 
with two of three axes being identical. In the fluid lamellar bilayer phase the axis of rotation 
of a phospholipid is aligned parallel to the local membrane normal, so is the least shielded 
element ???  (0° edge) of the averaged 
31P CSA tensor, resulting in the highest chemical shift. 
The most shielded perpendicular CSA element ??  (90° edge) results in the lowest chemical 
shift. 
Therefore, when lipid bilayers are macroscopically aligned, i.e. the molecular 
orientation is fixed with regard to the magnetic field, the resulting spectrum shows one 
narrow line. The exact position under a particular alignment is characteristic for a particular 
lipid. Oriented DMPC lipid bilayers, for example, at 0° alignment of their membrane normal 
with regard to the magnetic field, show a signal at about +30 ppm corresponding to ??? . Badly 
oriented lipid bilayers give rise to additional signals along the whole CSA range, in case of 
DMPC bilayers from approximately +30 up to about -15 ppm (??). Upon integration and 
comparison of signals at the 0° edge with the whole CSA range, the degree of the orientation 
of a sample can be determined. 
Multilamellar vesicles are concentric spheres of about 1 ?m in diameter. Suspensions 
of phospholipid vesicles due to spherical distribution of lipids, result in a characteristic shape 
of the spectrum with more lipids contributing to ??  than to ???  (Figure 2.17). 
 
 
Figure 2.17 Simulated solid state 
31
P-NMR spectrum of phospholipids in fluid lamellar 
bilayers in vesicles. The CSA tensor is axially symmetric due to rotation of lipids around the 
membrane normal. 
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2.3.5 
19
F-NMR as a tool to study antimicrobial peptides in lipid membranes 
In macroscopically aligned samples, when each type of molecule is oriented identically with 
regard to the magnetic field, above mentioned spin interactions and their orientational 
dependence may be employed to determine the orientation of a molecule. 
In this study the CF3-group with its characteristic chemical shift and dipolar splitting 
for a particular orientation with regard to the magnetic field serves as a reporter group for the 
helical antimicrobial peptide PGLa (Glaser 2004). Single CF3-groups are rigidly attached to 
the helix backbone of PGLa via the non-natural amino acid L-4-trifluoromethyl-
phenylglycine (CF3-Phg) (Figure 2.18) as substitutes for hydrophobic leucine or alanine 
residues. 
H2N
H
COOH
FF
F  
Figure 2.18 Chemical structure of 
CF3-Phg (L-4-trifluoromethyl-
phenylglycine) 
 
The dipolar coupling between the three identical 19F nuclei of the CF3-group results in a 
triplett in the spectrum (Figure 2.19). The CF3-group undergoes fast rotation around its axis 
(being equivalent to the C?-C? bond vector of CF3-Phg), leading to an averaged dipolar 
coupling with a reduced coupling constant ?FF0 =15,8kHz . The fast rotation will furthermore 
project all the three pair-wise dipolar couplings along the C?-C? bond vector. The angle ?  
between the C?-C? bond vector and the magnetic field can then be experimentally determined 
from the dipolar splitting ?FF =15,8kHz (3cos2? ?1) /2 (Figure 2.20) and the sign of the 
coupling can be determined when the CSA is taken into account. 
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Figure 2.19 Orientational dependence of chemical shift and 
homonuclear dipolar splitting of the CF3-group. The experimental 
powder spectrum is of randomly distributed polycrystalline CF3-
phenylglycine. The 0° and 90° edge of the axially symmetric CSA 
tensor and the positions of the corresponding tripletts are indicated. 
 
 
 
Figure 2.20 Dependence of the homonuclear dipolar splitting ?FF of 
the CF3-group on its orientation with regard to the magnetic field. 
?  is the angle between the C?-C? bond vector and B0. 
 
The parameters which describe the orientation of the peptide helix in the membrane are 
shown in Figure 2.21. The tilt angle?  is the angle between the helix axis and the membrane 
normal. The azimuthal rotation?  is defined as the right-handed rotation around the helix axis, 
with the axis directed from the N- to the C-terminus. At ? = 90°, ? = 0° is defined as the 
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orientation, when the vector projecting radially from the helix axis to the C? atom of Lys-12 
is aligned parallel to the membrane plane (compare to PGLa helical wheel in Figure 2.9). The 
molecular order parameter Smol describes the mobility of the molecule in the lipid bilayer 
(wobbling) as a factor between 0,0 (fully averaged system) and 1,0 (absence of wobble), 
reducing all NMR parameters by a constant factor. 
 
 
Figure 2.21 Parameters describing the orientation of a 
peptide helix in a lipid membrane (see text). The position of 
a CF3-group is scetched in red. 
 
The structure of a helix is generally reflected in the periodicity of an NMR parameter along 
its axis. Plotting an NMR parameter against the residue number, for instance the dipolar 
splitting, results in a wave-like curve with a repetition after 3,6 residues for an ?-helix. The 
orientation of the helix with regard to the magnetic field can be extracted from the shape and 
the frequency (relative and absolute) of the wave (Figure 2.22). 
 
Figure 2.22 Wave-like dependence of an NMR parameter on 
the reporter position along the ?-helix axis (from Strandberg 
2004b). 
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2.4 A note about membrane models 
NMR investigations of AMPs in synthetic lipid bilayers with a few well-defined components 
are employed to study the influence of individual parameters on the peptide-lipid interaction. 
The lipid environment may be adjusted to any desired condition by modification of, for 
instance, charge and size of the lipid head group, length and degree of unsaturation of the acyl 
chain, the ratio of the cross-sectional areas of both, the amount of water or the degree of 
membrane fluidity. 
Macroscopically aligned lipid bilayers are the most often used membrane model to 
determine structure, orientation and dynamics of a peptide in lipid environment. Fully 
hydrated, these lipid membranes do not contain excess bulk water, thus the affinity of 
peptides does not play a significant role in binding to the membrane, e.g. anionic lipids are 
not necessary. 
Multilamellar vesicle suspensions are employed to mimic more physiological 
conditions, i.e. with quasi unlimited supply of water. The advantage over aligned lipid 
systems is easier handling and that hydration and the bulk water content can be adjusted to 
any desired value. However, to reach the same effective peptide amount in the lipid 
membrane compared to oriented samples, dependent on charge of the membrane lipids, a 
higher P/L ratio may be necessary in this kind of sample, as peptides may escape into the 
water bulk. 
However, natural membranes are far more complex systems and contain various types 
of lipid and protein components. The direct determination of structural parameters for a 
peptide under this situation is difficult, if not impossible, and straightforward investigations 
on these systems may fail. It may be speculated that any results found for any uniform 
synthetic lipid model under certain conditions can be found in cytoplasmic membranes, 
perhaps simultaneously. For the understanding of the mode of action of AMPs in real 
biomembranes, spectra of peptide in synthetic lipid membranes representing different states 
under various defined conditions have to be used as reference for spectra of peptide in 
cytoplasmic membranes. 
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3 Aims and strategies 
The principle aim of this study was to determine the structure and orientation of PGLa in 
cytoplasmic membranes. Of particular interest was the question whether the different 
orientations observed for PGLa in synthetic lipid bilayers can also be identified in cell 
membranes of Bacteria and Eukarya, and if any principal differences can be found that may 
be rationalized in terms of the selective activity of the peptide. 
Solid state NMR spectroscopy was used to observe the membrane orientations of 
PGLa. The highly sensitive and in biological samples background-free 19F nucleus was used 
as an NMR label. Hydrophobic amino acids Ile-9, Ala-10, Ile-13 or Ala-14 of PGLa were 
singly substituted by the non-natural amino acid 4-CF3-phenylglycine. These labeled PGLa 
analoga were synthesized in our group and were previously shown to be structurally and 
functionally intact, i.e. neither severe disturbance of the helical structure nor alteration of 
antimicrobial activity occured (Strandberg 2006; Ulrich 2004; Glaser 2004). The orientational 
dependence of dipolar coupling and chemical shift of the CF3-group rigidly attached to the 
helix backbone was employed as a reporter for the orientation and dynamics of the peptide in 
membranes.  
One main challenge in this study was the preparation of cell membranes in sufficient 
yield and purity to be employed as vesicle suspensions and macroscopically aligned 
membranes in solid state NMR spectroscopy. Two common systems representing cells of 
Eukarya and Bacteria were finally chosen: human erythrocytes and Micrococcus luteus. 
Human erythrocyte membranes are the most often used model for eukaryotic membranes in 
biophysical and biochemical studies. Their clinical relevance is obvious. Since cells are 
osmotically sensitive, membranes could be accessed directly. Among Gram-positive bacteria, 
Bacillus subtilis and Micrococcus luteus are excellent models for studying pathogenic 
bacteria and are themselves responsible for nosocomial infections. Furthermore, in contrast to 
Gram-negative bacteria, their membrane preparations do not involve time-consuming and 
yield-reducing separation steps. After initial attempts on Bacillus subtilis, however, a decision 
was made in favour of M. luteus. It is usually highly sensitive to lysozyme, making its cell 
membrane easily accessible. Its envelope, furthermore, lacks phosphorus-containing teichoic 
acids, which were assumed in B. subtilis to be responsible for disturbance of solid state 31P-
NMR spectra. 
Heterogenity and complex phase behaviour of real biomembranes, prior to application 
of 19F-labeled PGLa to cell membrane preparations, required characterization of structure and 
orientation of peptide in simple model systems. Two such model systems of different 
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hydration levels were employed. Macroscopically aligned bilayers are adequate for the 
determination of structural NMR parameters. Multilamellar vesicles of high water bulk 
content resemble the native situation in biomembrane vesicles more closely. DMPC and 
DMPG at a 3/1 ratio provide an experimentally accessible gel as well as fluid bilayer phase 
and supply sufficient amounts of negative charge to bind cationic PGLa even at high water 
bulk content. For all four 19F-labeled PGLa analoga at high P/L ratio of 1/50, a detailed 
investigation of temperature-dependence of dipolar splittings was performed, followed by the 
determination of orientational parameters of PGLa, thus giving a set of spectra for all 
alignment states of PGLa (S, T and I). From 2H-NMR experiments, magainin 2 is known to 
stabilize an inserted alignment state of PGLa. Therefore, the same temperature-dependent 
experimental procedure was undertaken in presence of unlabeled magainin 2 at equimolar 
ratio to obtain 19F-NMR spectra for PGLa in the I-state. 
The most appropiate labeled PGLa analogue (13CF3-Phg PGLa) was selected 
thereafter as a reporter reference to identify the respective states of PGLa in cell membranes 
of human erythrocytes and Micrococcus luteus both in vesicle suspensions and as oriented 
membranes. 
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4 Solid state NMR studies of PGLa in synthetic lipid bilayers in 
the presence or absence of magainin 2 
4.1 Materials and methods 
4.1.1 Instruments 
Balance M2P Sartorius (acc. 0,0001 mg) Mettler Toledo (Greifensee, Switzerland) 
Centrifuge Biofuge Pico Heraeus (Hanau, Germany) 
Diaphragm vacuum pump Vacuubrand (Wertheim, Germany) 
Microsyringes 
(10 ?l; 25 ?l; 1000 ?l) 
Hamilton (Bonaduz, Switzerland) 
NMR spectrometer Avance 500 
    Probehead for 31P H/X/Y 
    Probehead for 19F Doty 
Bruker Biospin (Karlsruhe, Germany) 
Bruker Biospin (Karlsruhe, Germany) 
Doty Scientific (Columbia, SC, USA) 
Oven B5042 Heraeus (Hanau, Germany) 
Pipettes Reference 
(0,5-10 ?l; 10-100 ?l; 100-1000 ?l) 
Eppendorf (Hamburg, Germany) 
Sonifier Bandelin Sonorex Super RK510 Schalltec (Berlin, Germany) 
Vortex mixer Genie K-550-GE Bender & Hobein (Zurich, Switzerland) 
4.1.2 Consumables 
Centrifuge tubes 
(15 ml; 50 ml) 
Sarstedt (Nuembrecht, Germany) 
Glass plates (18 x 7,5 x 0,08 mm) Marienfeld Laboratory Glassware (Lauda- 
Königshofen, Germany) 
Parafilm American National Can (Chicago, IL, USA) 
Pipette tips Sarstedt (Nümbrecht, Germany) 
Reaction tubes 
(0,5 ml; 1,5 ml; 2,0 ml) 
Sarstedt (Nuembrecht, Germany) 
4.1.3 Chemicals 
CHCl3 Merck (Darmstadt, Germany) 
K2SO4 Roth (Karlsruhe, Germany) 
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Methanol Fischer Scientific (Leicestershire, UK) 
Silica gel Merck (Darmstadt, Germany) 
4.1.4 Lipids 
Dimyristoylphosphatidylcholine (DMPC) Avanti Polar Lipids (Alabaster, AL, USA) 
Dimyristoylphosphatidylglycerol (DMPG) Avanti Polar Lipids (Alabaster, AL, USA) 
4.1.5 Peptides 
4-CF3-Phg-labeled analogues of Peptidyl-glycine-leucine-carboxyamide (PGLa) (Table 4.1) 
and unlabeled magainin 2 were synthesized in our group by standard Fmoc (9-
fluorenylmethoxycarbonyl) solid phase peptide synthesis (Fields 1990). Peptides were 
purified to more than 95 % purity by RP-HPLC and characterized by MALDI-TOF and 
Marey assay. 
Table 4.1 Amino acid sequences of peptides used in this study. For comparison with labeled analoga the 
sequence of unlabeled PGLa is given. 
 
Peptide Labeled position Sequence 
PGLa wt   - GMASKAGAIAGKIAKVALKAL-NH2 
9CF3-Phg PGLa Ile-9 GMASKAGA-4-CF3-Phg-AGKIAKVALKAL-NH2 
10CF3-Phg PGLa Ala-10 GMASKAGAI-4-CF3-Phg-GKIAKVALKAL-NH2 
13CF3-Phg PGLa Ile-13 GMASKAGAIAGK-4-CF3-Phg-AKVALKAL-NH2 
14CF3-Phg PGLa Ala-14 GMASKAGAIAGKI-4-CF3-Phg-KVALKAL-NH2 
Magainin 2  - GIGKFLHSAKKFGKAFVGEIMNS 
4.1.6 Software 
TopSpin 2.0 (Bruker) 
XWinNMR (Bruker) 
FITPS program (written by Dr. Erik Strandberg of our group) 
dmfit (Massiot 2002) 
Illustrator 10 (Adobe) 
Excel 2004 for Mac Version 11 (Microsoft) 
Photoshop 7 (Adobe) 
Power Point 2004 for Mac Version 11 (Microsoft) 
Word 2004 for Mac Version 11 (Microsoft) 
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4.1.7 Preparation of oriented lipid bilayers 
Macroscopically aligned lipid bilayers were prepared according to common protocols with 
some modifications (Strandberg 2006; Strandberg 2004b). 
Thin glass plates (18 mm x 7,5 mm x 0,08 mm) were washed with methanol and dried 
under vacuum for 2 h. Appropiate amounts of DMPC, DMPG and peptide(s) to obtain the 
desired molar ratios were codissolved in 400 to 600 ?l methanol/CHCl3 (1/1 (v/v)), resulting 
in about 1 mg of total material per glass plate (dissolved in 20-30 ?l) for up to 20 glass plates 
in total. Aliquots were deposited onto the glass plates, dried in air for about 1 h, followed by 
drying under vacuum overnight (about 12 h). The glass plates were stacked, covered with an 
additional clean glass plate and hydrated at 96 % relative humidity (over a saturated solution 
of K2SO4) at 46 °C for 24-48 h. The stacks were wrapped in parafilm and a polyethylene foil. 
Samples were stored at -20 °C when not used. 
4.1.8 Preparation of multilamellar vesicle samples 
Multilamellar vesicles were prepared according to common protocols with some 
modifications (Strandberg 2006; Strandberg 2004b). 
Appropiate amounts of DMPC, DMPG and peptide(s) (typically 1-4 mg) to obtain 
desired molar ratios were codissolved in up to 500 ?l methanol/CHCl3 (2/1 (v/v)). The 
solution was dried under a gentle stream of N2, followed by drying under vacuum over night 
(about 12 h). Double-destilled water was added to the dry lipid-peptide mixture to obtain 60 
% water (v/w). The sample was thoroughly mixed by vortexing and freeze-thawed about 
eight times. The material was then transferred with a spatula into a small polyethylene bag 
which was heat sealed and packed into a second bag. The samples were stored at -80 °C when 
not used. 
4.1.9 Solid state NMR spectroscopy 
All measurements were carried out on a widebore Bruker Avance 500 MHz NMR 
spectrometer (Bruker Biospin, Karlsruhe, Germany) at a transmitter frequency of 470,6 MHz 
(19F) and  202,5 MHz (31P). 
For solid state 19F-NMR a 19F/1H double-tuned flat-coil probehead (Doty Scientific, 
Columbia, SC) equipped with a goniometer was used. Oriented samples were aligned with the 
lipid membrane normal either parallel or perpendicular to B0. Between 2000 and 12000 scans 
were aquired for single-pulse 19F-NMR spectra with 1H-decoupling. Spectra were referenced 
against externally measured 100 mM NaF solution aquired at 308 K which was set to -119,5 
ppm (Glaser 2003). 
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For solid state 31P-NMR a 1H/X/Y probehead with interchangeable flat-coils for 
horizontal or vertical alignment of samples was used. Oriented samples were aligned with the 
membrane normal parallel or perpendicular to B0. 
31P-NMR spectra were usually aquired at 
308 K. 1H-decoupled Hahn-echo spectra were recorded with a typical 90° pulse duration of 6 
?s, relaxation delay of 2 s and inter-pulse echo delay of  30 ?s. The number of scans was 
typically 512 for oriented samples and 1024 for multilamellar vesicles. Spectra were 
referenced against externally measured 85% H3PO4 solution aquired at 308 K which was set 
to 0 ppm. 
4.1.10 Calculation of the helix orientation 
To describe the orientation of PGLa in synthetic lipid bilayers, a molecular frame was 
defined, where the z-axis is the helix axis of the peptide and the C? atom of Lys-12 lies in the 
bilayer plane (y-axis). For an explanation of the angles describing the orientation of the helix 
in the laboratory frame, i.e. in the oriented lipid bilayer, see Figure 2.21. 
The angles ?, ? and ? describe the orientation of an amino acid side chain in the ?-
helix. ? is the angle between the projection of the C?-C? bond vector of a particular amino 
acid in the xy-plane and the vector pointing radially from the the helix axis to the C? atom. ? 
is the angle between the helix axis and the C?-C? bond vector. ? describes the pitch angle 
between the C? atom and the C? atom of the subsequent residue. For a “standard“ ?-helix 
(poly-Ala) the characteristic values for ?, ? and ? are 53,2°, 121,1° and 99,8°, respectively. 
As CF3-Phg induces some structural distortions, an energy-minimized model of PGLa was 
employed, with angles 47,0°, 110° and 100,0° respectively (Glaser 2004; Strandberg 2004a; 
Dürr 2005). 
The signed dipolar splittings for the individual labels were calculated for different 
peptide orientation with regard to the magnetic field, and a grid search of ?, ? and Smol was 
performed to find the smallest root mean square deviation (RMSD) between the calculated 
values and the experimental data (Glaser 2004; Strandberg 2004b; Ulrich 2004). The RMSD 
are visualized in a ?/?-diagram, giving the difference between the calculated values and the 
experimental data for each orientation of the peptide. Calculations were performed with a 
program written by Dr. Erik Strandberg from our group. 
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4.2 Results 
4.2.1 
31
P-NMR 
31P-NMR spectra of DMPC/DMPG (3/1) prepared as multilamellar vesicles, in the presence 
of peptide, show broad spectra with a CSA range of about 45 ppm in the gel phase as well as 
in the fluid phase. This is characteristic for lamellar lipid bilayers and furthermore 
corresponds to the respective spectra of pure lipids. Typical 31P-NMR spectra at 308 K are 
shown in Figure 4.1. In oriented bilayers from the same lipids with the membrane normal 
parallel to the magnetic field, signals with high chemical shift (0° edge) correspond to the 
oriented fraction of phospholipids. Other signals along the spectrum up to the 90° edge derive 
from nonoriented lipids. Upon integration of signal at the 0° edge and comparison with the 
whole CSA range, the fraction of oriented phospholipid can be determined. Synthetic bilayers 
were oriented between 60 % and far above 90 %. Separated peaks of the lipid components 
DMPC and DMPG are observed only rarely and irregularly. The ratio of signal intensities in 
these cases is approximately 3 to 1, as determined by integration if the peaks, corresponding 
to the applied molar ratio of DMPC and DMPG. No indications for isotropic or nonlamellar 
phases can be detected in either type of sample. 
 
Figure 4.1 Representative solid state 
31
P-NMR spectra from DMPC/DMPG (3/1), measured at 308 K. All 
samples at high P/L ratio (1/50), either PGLa alone (lower two rows) or at 1/1 ratio with magainin 2 
(upper two rows). Phospholipids in oriented bilayers at 0° tilt (left column) show orientation to an extent of 
well over 90 % in the presence of 14CF3-Phg PGLa. In the presence of 13CF3-Phg PGLa together with magainin 
2, phospholipids are oriented to about 60 %. In this sample the whole CSA range up to the 90° edge can be 
identified. Individual peaks can be identified for DMPC and DMPG with 13CF3-Phg PGLa. Intensities 
correspond to the lipid ratio of 3/1 as determined by integration. All multilamellar vesicles (right column) show 
lipids being in the lamellar phase. No signs for isotropic or nonlamellar lipids can be found. 
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4.2.2 Concentration-dependent realignment and mobility of 13CF3-Phg PGLa in 
fluid oriented bilayers 
19F-NMR spectra of 13CF3-Phg PGLa at low (1/200) and high (1/50) P/L ratio in oriented 
DMPC/DMPG (3/1) bilayers are shown in Figure 4.2. It was already demonstrated by a set of 
four singly 19F-labeled PGLa analogues in oriented bilayers of pure DMPC (Glaser 2005), 
that PGLa undergoes a concentration-dependent realignment from a surface-bound state (S-
state) to a tilted state (T-state) (2.2.4.1), reflected in a characteristic change of dipolar 
splitting of 13CF3-Phg PGLa from +5,6 kHz to -3,3 kHz. It was further shown on 13CF3-Phg 
PGLa that the qualitative change of the spectrum is not influenced by the introduction of 
negative charges into the lipid bilayer, namely in DMPC/DMPG bilayers, but that the 
orientational behaviour of PGLa is the same in both lipid systems. 
 
As a starting point for the upcoming investigations, 19F-NMR spectra were recorded from 
13CF3-Phg PGLa in oriented DMPC/DMPG (3/1) bilayers (Figure 4.2, upper row), showing 
dipolar splittings of +6,0 kHz at low (1/200) P/L ratio and of -2,5 kHz at high (1/50) P/L 
ratio, being characteristic for S-state and T-state, respectively. 
In addition, upon tilting the samples to 90°, dipolar splittings scaled around the 
isotropic position by about -1/2 (Figure 4.2, lower row). This is indicative for fast rotation of 
13CF3-Phg PGLa around the normal of fluid DMPC/DMPG (3/1) bilayers, and is consistent 
with previous data for pure DMPC bilayers. 
 
Figure 4.2 Solid state 
19
F-NMR spectra of 13CF3-Phg PGLa in oriented DMPC/DMPG (3/1) bilayers at 
low (1/200) (left column) and high (1/50) (right colomn) P/L ratio at 0° (upper row) and 90° (lower row) 
tilt of sample membrane normal with regard to the magnetic field. Dipolar splittings are given as averages 
above each spectrum. Positions of peaks are indicate above. The dipolar splittings in spectra at P/L of 1/50 at 0° 
and 90° tilt are estimated with an accuracy of 0,5 kHz. 
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4.2.3 Temperature-dependent behaviour of 13CF3-Phg PGLa at low P/L ratio 
(1/200) in oriented bilayers 
At low P/L ratio (1/200) in oriented DMPC/DMPG (3/1) bilayers, 13CF3-Phg PGLa shows  a 
temperature-dependent change of the dipolar splitting at 0° as well as at 90° tilt (Figure 4.3).  
At all temperatures spectra show orientation of peptide. Spectral lines are broader and dipolar 
splittings larger at lower temperatures, showing an abrupt change of features upon elevation 
of temperature to 298 K and above, i.e. upon transition of the membrane to the fluid phase 
(Lewis 2005). Upon further increase in temperature lines sharpen and splittings decrease. 
Below Tm PGLa is surface-aligned, but motionally restricted, as spectra at 90° tilt show broad 
distributions of signals comparable to unoriented immobilized peptides. From 298 K 
upwards, scaling of dipolar splitting around the isotropic position by a factor of -1/2 upon tilt 
of sample (Table 4.2) shows fast rotational mobility around the membrane normal of 13CF3-
Phg PGLa in the S-state. 
 
 
Figure 4.3 Solid state 
19
F-NMR spectra of 13CF3-Phg PGLa in oriented DMPC/DMPG (3/1) bilayers at 
low P/L ratio (1/200) at different temperatures. The sample is aligned with its membrane normal at 0° 
(left column) and 90° (right column) to the magnetic field. Values of the corresponding dipolar splittings are 
given next to each spectrum. 
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Table 4.2 Dipolar splittings for 13CF3-Phg PGLa in oriented DMPC/DMPG (3/1) bilayers at low P/L 
ratio (1/200) at 0° and 90° tilt. Last column shows dipolar splitting at 90° tilt multiplied by (-2). Scaling 
around the isotropic position by -1/2 indicating peptide mobility can be observed from 298 K upwards (see 
text). 
 
T [K] ?FF [kHz] ?FF (90°) * (- 2) 
 0° 90°  
328 + 6,0 - 2,9 + 5,8 
308 + 6,2 - 2,8 + 5,6 
298 + 7,8 - 3,1 + 6,2 
288 + 8,2 - 7,4 + 14,8 
273 + 8,5 - 8,0 + 16,0 
 
4.2.4 Temperature-dependent behaviour of 13CF3-Phg PGLa at low P/L ratio 
(1/200) in multilamellar vesicles 
Spectra of 13CF3-Phg PGLa at low P/L ratio (1/200) in multilamellar vesicles of 
DMPC/DMPG (3/1) at a hydration of 60 % (v/w) exhibit a temperature-dependent change of  
the line shape. Below Tm spectra have dipolar splittings of approximately -7 kHz. Spectra 
show an abrupt change around Tm and a continuous development of splitting upon further 
increase in temperature (Figure 4.4). 
 
Figure 4.4 Solid state 
19
F-NMR spectra of 13CF3-Phg PGLa in multilamellar vesicles of DMPC/DMPG 
(3/1) at low P/L ratio (1/200) at different temperatures. Values if the corresponding dipolar splittings are 
given next to each spectrum. 
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Above Tm spectra suggest a surface alignment of rotationally mobile 13CF3-Phg PGLa. 
Peptide molecules at the equator of the vesicles exhibit a dipolar splitting corresponding to 
oriented samples at 90° tilt (Figure 4.3), contributing most to the signal intensity of the 
spectrum on the high field side (compare to 31P-NMR spectra of phospholipids (2.3.4)). 
Reflecting the decrease in number of peptide molecules closer to the poles, the signal 
intensity drops to the low field side. 
4.2.5 Temperature-dependent realignment of PGLa at high P/L ratio (1/50) in 
oriented bilayers 
PGLa is known to adopt a T-state at high P/L ratio (1/50) in oriented DMPC and 
DMPC/DMPG bilayers at ambient temperature (2.2.4.1). A temperature series performed at 
high P/L ratio (1/50) of 13CF3-Phg PGLa in oriented DMPC/DMPG (3/1) bilayers as for low 
P/L ratio (1/200) above (Figure 4.3), revealed a significant change in the line shape of 
spectra, indicating a temperature-dependence of PGLa alignment. Therefore, the whole set of 
CF3-Phg-labeled PGLa analogues was tested at different temperatures. 
 
In the temperature range from 273 to 328 K, the line shape of 19F-NMR spectra of CF3-Phg-
labeled PGLa shows three major situations, changing discretely with increase in temperature. 
Spectra are shown in Figure 4.5. Dipolar splittings are summarized in Table 4.3. All spectra 
exhibit the expected triplet signals, having distinct splittings over the three different 
temperature ranges 273-288 K, 298-308 K and 318-328 K. Splittings of 9CF3-Phg and 10CF3-
Phg PGLa at elevated temperature do not reflect a rapidly tumbling peptide, but happen to be 
zero for geometric reasons, as becoming apparent from 2.3.5 and from the fact that splittings 
of other labeled peptides in Figure 4.5 have values different from zero. The line shape of 
spectra of 14CF3-Phg PGLa shows the transition between these distinct states, as the middle 
peaks of the respective triplets can be identified side by side around 288 and 298 K. A similar 
transient overlap of signals can be found for 13CF3-Phg PGLa at 318 K. For further analysis 
only the most predominant situation among the whole set of spectra at each temperature was 
taken into account. 
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Figure 4.5 Solid state 
19
F-NMR spectra of CF3-Phg-labeled PGLa analogues (labeled position given on top 
of each column) in oriented DMPC/DMPG (3/1) bilayers at high P/L ratio (1/50) at different temperatures 
at 0° tilt. Due to experimental difficulties, one spectrum is lacking. 
 
Table 4.3 Dipolar splittings for different CF3-Phg-labeled PGLa analogues in oriented DMPC/DMPG 
(3/1) bilayers at high P/L ratio (1/50). 
 
T [K] ?FF [kHz] 
 I9 A10 I13 A14 
328 0 0 + 5,9 - 4,6 
323 - 1,0 n/a + 6,3 - 5,1 
318 - 2,5 0 + 6,0 - 5,1 
308 - 4,5 - 3,4 - 2,3 - 5,3 
298 - 4,6 - 5,0 - 2,8 - 5,5 
288 - 2,6 - 5,8 - 3,8 - 6,5 
273 - 2,7 - 6,0 - 4,0 - 6,5 
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To describe the alignment of PGLa in the lipid bilayer, the helix tilt angle ?, the azimuthal 
rotation angle ? and the molecular order parameter Smol quantifying the motional averaging 
(2.3.5) were determined as described in section 4.1.10. 
A full list of calculated best fit parameters is presented in Table 4.4. For data collected 
at 288, 308 and 328 K, being representative for the three major situations, in Figure 4.6 the 
best fit curves and the ?/?-diagrams are displayed in the left and right column, respectively. A 
T/?-diagram is shown in Figure 4.7. 
 
 
 
 
Figure 4.6 Best fit curve (left) and ? /?-diagram (right) for CF3-Phg-labeled PGLa analogues in 
DMPC/DMPG (3/1) at high P/L ratio (1/50) showing the characteristic situation for each of the three 
temperature ranges. Dashed lines indicate the angles ? and ? corresponding to the global minima. 
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Table 4.4 Full list of best-fit orientational parameters from data in Table 4.3. 
 
T [K] Smol Tilt [°] Rotation [°] RMSD [kHz] 
328 0,6 96 113 0,2 
323 0,7 98 111 0,0 
318 0,7 102 108 0,4 
308 0,6 131 101 0,3 
298 0,7 134 110 0,4 
288 1,0 172 3 0,1 
273 0,9 172 11 0,0 
 
For each set of triplets one unique well-defined minimum can be found. PGLa adopts a tilted 
alignment (T-state) at 298 and 308 K as previously found in DMPC and DMPC/DMPG lipid 
bilayers at ambient temperature (2.2.4.1). However, temperatures beyond that range show a 
clearly different situation. An inserted and almost upright orientation (I-state) is found at 273 
and 288 K, a surface alignment (S-state) is found at elevated temperatures above 308 K. The 
order parameter S, describing the peptide wobble, adopts its maximum value of close to 1,0 
below Tm, reflecting much lower mobility in the lipid bilayer gel phase as compared to the 
fluid phase. A diagram showing all tilt angles as a function of temperature is displayed in 
Figure 4.7. For each alignment state, a plateau can be found in the diagram. For the T- and the 
S-state, a slight decline in ? within each state is observed. 
 
Figure 4.7 Temperature-dependence of PGLa tilt angle in oriented DMPC/DMPG (3/1) bilayers at 
high P/L ratio (1/50). Data points are connected for an easier identification. Grey bar indicates main phase 
transition temperature (Tm) of the pure lipid mixture (according to Lewis 2005). 
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At temperatures of about 298 K and higher, upon tilt of samples by 90°, spectra can be found 
to scale around the isotropic position by a factor of -1/2 (Figure 4.8 and Table 4.5), indicating 
rotational mobility of PGLa around the membrane normal. From about 298 K downwards, the 
spectral line shape indicates that this motion is significantly slowed down or stopped. At 
temperatures close to Tm the transition can be observed as the coexistence of two states as 
also seen at 0° tilt (compare to Figure 4.5). 
 
Figure 4.8 Solid state 
19
F-NMR spectra of CF3-Phg-labeled PGLa analogues (labeled position given on 
top of each column) in oriented DMPC/DMPG (3/1) bilayers at high P/L ratio (1/50), at different 
temperatures at 90° tilt. Values of the corresponding dipolar splittings [kHz] are given next to each spectrum. 
The dipolar splitting of I9 up to 298 K are estimated with an accuracy of 0,5 kHz. Corresponding spectra at 0° 
tilt are shown in Figure 4.5. 
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Table 4.5 Dipolar splittings for different CF3-Phg-labeled PGLa analogues in oriented DMPC/DMPG 
(3/1) bilayers at high P/L ratio (1/50) at 0° and 90° tilt, as read from spectra in Figure 4.8. The last two 
columns show dipolar splittings at 90° tilt multiplied by (-2). Scaling of splittings due to rotation of peptide 
around the bilayer normal can be observed from 298 K upwards (see text). 
 
4.2.6 Temperature-dependent realignment of PGLa at high P/L ratio (1/50) in 
multilamellar vesicles 
All four PGLa analogues as above were used to check if temperature-dependent realignment 
takes place in multilamellar vesicles likewise in oriented samples above. Thereby fingerprint 
spectra of 13CF3-Phg with regard to dipolar splitting and chemical shift for the different 
states observed in oriented samples were obtained, for later comparison with spectra of 
13CF3-Phg PGLa in native membrane vesicles from erythrocytes and M. luteus. Fitting of the 
dipolar splittings as in oriented samples was not performed, as splittings were comparatively 
small and poorly resolved throughout and would not have delivered more and sufficiently 
accurate information compared to oriented lipid bilayers. 
 
Spectra of PGLa at high P/L ratio (1/50) in multilamellar vesicles of DMPC/DMPG (3/1) at  a 
hydration of 60 % (v/w) show a temperature-dependent change of line shapes in the range of 
288 K to 323 K. Spectra are shown in Figure 4.9. Dipolar splittings are summarized in Table 
4.6. 
 
T [K] ?FF [kHz] ?FF (90°) * (-2) 
 I9 A14 I9 A14 
 0° 90° 0° 90°   
328 0 0 - 4,6 + 2,2 0 - 4,4 
308 - 4,5 + 2,2 - 5,3 + 2,7 - 4,4 - 5,4 
298 - 4,6 + 2,5 - 5,5 - 8,4 - 5,0 + 16,8 
288 - 2,6 - 2,5 - 6,5 - 7,4 + 5,0 + 14,8 
273 - 2,7 - 5,0 - 6,5 - 7,5 + 10,0 + 15,0 
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Figure 4.9 Solid state 
19
F-NMR spectra of CF3-Phg-labeled PGLa analogues (labeled position given on top 
of each column) in multilamellar vesicles of DMPC/DMPG (3/1) at high P/L ratio (1/50) at different 
temperatures. Due to experimental difficulties, a few spectra are lacking. 
 
Up to 298 K, all labeled PGLa analogues exhibit dipolar splittings close to -7 kHz. At higher 
temperatures, i.e. in the fluid phase, spectra are significantly different, exhibiting further 
continuous changes in line shape and splittings upon an increase in temperature. 14CF3-Phg 
PGLa exhibits positive dipolar splittings of slightly above +2 kHz throughout. The isotropic-
like signal from 10CF3-Phg PGLa does not allow dipolar splittings to be determined. 9CF3-
Phg PGLa exhibits splitting of +2 kHz at 303 K and a transition to an apparently isotropic 
signal at elevated temperature. 13CF3-Phg PGLa shows no obvious splitting at 303 K, but 
evolves a splitting of about -2 kHz upon increase in temperature. 
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Table 4.6 Dipolar splittings for different CF3-Phg-labeled PGLa analogues in multilamellar vesicles of 
DMPC/DMPG (3/1) at high P/L ratio (1/50). Dipolar splitting of I9 between 303 K and 318 K and of I13 
between 313 K and 323 K are estimated with an accuracy of 0,5 kHz. 
 
T [K] ?FF [kHz] 
 I9 A10 I13 A14 
323 n/a 0 - 2,0 n/a 
318 + 0,5 0 - 1,5 + 2,1 
313 + 1,0 0 - 1,0 + 2,2 
308 + 1,5 0 0 + 2,3 
303 + 2,0 0 0 + 2,5 
298 - 6,9 - 7,3 - 7,3 - 7,2 
293 - 7,4 - 7,5 - 7,1 - 7,4 
288 - 7,6 n/a - 7,3 - 7,4 
 
A comparison of dipolar splittings from multilamellar vesicles with those of oriented samples 
reveals a corresponding temperature-dependent realignment of PGLa in the fluid lamellar 
lipid phase. Contrary to oriented samples, in multilamellar vesicles this change appears to be 
gradual. Line shapes of 14CF3-Phg PGLa in multilamellar vesicles throughout the whole 
temperature range above 298 K may correspond to the T-state as well as the S-state (Figure 
4.5, Table 4.3). The maximum signal for both states in vesicles is expected to be found at the 
low field side with a dipolar splitting of approximately +2,5 kHz (Table 4.5, Figure 4.8). In 
Figure 4.10 spectra of 9CF3-Phg PGLa at 303 K and 13CF3-Phg PGLa at 323 K are expanded 
from Figure 4.9. At 303 K, a positive dipolar splitting of 9CF3-Phg PGLa indicates a tilted 
alignment. 13CF3-Phg PGLa excludes a surface alignment and the isotropic-looking signal 
indicates that PGLa is tilted. With increasing temperature up to 323 K, 13CF3-Phg PGLa 
exhibits negative dipolar splitting as expected for the S-state. Correspondingly, 9CF3-Phg 
PGLa shows a continuous decrease of dipolar splitting. Measurements of 9CF3-Phg PGLa and 
14CF3-Phg PGLa at the highest temperature are lacking for experimental difficulties, but the 
tendency of both is obvious. Poor resolution of the isotropic-looking signal from 10CF3-Phg 
PGLa does not allow for a differentiation between surface and tilted alignment for the whole 
temperature range on this label. 
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Figure 4.10 Spectra of 9CF3-Phg PGLa at 303 K (upper) and 13CF3-Phg PGLa at 323 K (lower) in 
multilamellar vesicles of DMPC/DMPG (3/1) at high P/L ratio (1/50). Dipolar splittings are estimated with 
an accuracy of 0,5 kHz. 
 
4.2.7 Temperature-dependent realignment of PGLa in the presence of magainin 
2 (1/1) at high P/L ratio (1/50) in oriented bilayers 
By 2H-NMR spectroscopy, PGLa was previously shown to adopt an upright inserted 
alignment (I-state) in the presence of magainin 2 at a high P/L ratio (1/50) in oriented 
DMPC/DMPG bilayers at ambient temperature (2.2.4.3). In order to obtain 19F-NMR spectra 
of 13CF3-Phg PGLa in this inserted state, later to be used as reference for cytoplasmic 
membranes, spectra of all four CF3-Phg-labeled PGLa analogues were recorded in a 
temperature series, as results above (4.2.5) revealed the alignment of PGLa to be temperature-
dependent. 
 
In the 1/1/75/25 molar ratio of PGLa/magainin/DMPC/DMPG, 19F-NMR spectra of CF3-Phg-
labeled PGLa show a temperature-dependent change of line shape upon increase in 
temperature from 288 K to 328 K (Figure 4.11). Under all conditions, spectra indicate a 
specific orientation of peptide and exhibit the expected triplet signals. Isotropic signals in 
spectra of 9CF3-Phg and 10CF3-Phg PGLa at elevated temperatures do not reflect a rapidly 
tumbling peptide, as already explained in 4.2.5. 
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Figure 4.11 Solid state 
19
F-NMR spectra of CF3-Phg-labeled PGLa analogues (labeled position given on 
top of each column) with magainin 2 (1/1) in oriented DMPC/DMPG (3/1) bilayers at high P/L ratio (1/50) 
at different temperatures at 0° tilt. 
 
Up to 298 K, spectra of 13CF3-Phg PGLa in fact exhibit two triplet signals, indicating the 
coexistence of two discrete states. The spectrum of 13CF3-Phg PGLa at 298 K, showing both 
triplets most pronounced, is expanded in Figure 4.12. However, no additional triplet can 
unambiguously be identified among the spectra of the other labeled peptides. 
 
 
Figure 4.12 Spectrum of 13CF3-Phg PGLa with magainin 2 (1/1) in oriented DMPC/DMPG (3/1) bilayers 
at high P/L ratio (1/50) at 298K.  
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Between 298 and 303 K, spectra of all labeled peptides exhibit an abrupt change of line 
shape. This is especially pronounced in the spectrum of 13CF3-Phg PGLa, where one of the 
two triplets vanishes. In the spectra of 14CF3-Phg PGLa, a significant drop in the value of the 
dipolar splitting can be observed. Upon further increase in temperature, all spectral line 
shapes gradually change. On the one hand, dipolar splittings alter slightly. On the other hand, 
among 9CF3-Phg and 10CF3-Phg PGLa, the intensities of a part of their triplets can be 
observed to drop. For instance, for 10CF3-Phg PGLa only one signal with a broadened basis 
remains around the isotropic position. Dipolar splittings read from spectra in Figure 4.11 are 
summarized in Table 4.7. 
 
Table 4.7 Dipolar splittings of CF3-labeled PGLa analogues in the presence of magainin 2 (1/1) at high 
P/L ratio (1/50) in oriented DMPC/DMPG (3/1) bilayers. Up to 298 K two triplets can be identified in the 
spectra of 13CF3-Phg PGLa. 
 
T [K] ?FF [kHz] 
 I9 A10 I13 A14 
328 - 5,8 0,0 - 6,4 - 4,7 
323 - 5,7 0,0 - 6,4 - 4,8 
318 - 5,5 - 3,0 - 6,3 - 4,8 
313 - 4,9 - 3,6 - 6,1 - 4,9 
308 - 4,7 - 3,8 - 5,9 - 4,8 
303 - 4,6 - 4,1 - 5,8 - 4,7 
298 - 5,1 - 5,3 + 8,1 / - 4,9 - 6,1 
293 -5,7 - 5,5 + 8,3 / - 7,1 - 6,5 
288 - 6,2 ? + 7,8 / - 6,0 - 6,7 
 
To describe the alignment of PGLa in the lipid bilayer, orientational parameters were 
determined from the measured dipolar splittings, as described in sections 4.2.5 and 4.1.10. 
Spectra of all CF3-labeled PGLa analogues at temperatures just above 298 K show 
only one single well-defined set of triplets, representing one distinct alignment state for 
PGLa, and can thus be assigned to each other. At further elevated temperatures, a 
redistribution between two distinct states may be suggested. Contrary to spectra from 298 K 
downwards, however, no additional triplet of that evolving state can be identified clearly. 
Without an indication for that state, signals cannot unambiguously be assigned. Therefore, for 
further analysis only the most predominant situation among the whole set of spectra was 
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taken into account. The corresponding best fit curves and ?/?-diagrams for temperatures 
above 298 K are shown in Figure 4.15. 
From 298 K downwards, one set of dipolar splittings can be assigned to each other 
corresponding to those at temperatures above 298 K. This procedure is supported by previous 
solid state 2H-NMR studies, as explained above. PGLa was demonstrated to adopt an upright 
orientation in the presence of magainin 2 at ambient temperature. Hence, it is reasonable to 
assign negative dipolar splittings to another, as observed in 4.2.5. The resulting best fit curves 
and ?/?-diagrams for this first set of splittings are shown in Figure 4.13. After the assignment 
of that set of dipolar splittings, the only undoubtedly identifiable triplet remaining is that of 
13CF3-Phg PGLa. Considering the amphipathicity of the peptide, the positive dipolar splitting 
suggests a surface alignment of PGLa (compare to 4.2.2, 4.2.3 and 4.2.5). In fact, the positive 
component of the spectrum and the corresponding dipolar splitting of 13CF3-Phg PGLa at 
298 K displayed in Figure 4.12 show considerable similarity to Figure 4.3, representing an 
immobilized and surface-aligned 13CF3-Phg PGLa. For the assumed surface alignment of the 
peptide, 9CF3-Phg and 10CF3-Phg PGLa are expected to exhibit an isotropic signal (Figure 
4.5), which could not be identified underneath the present triplets. Structural analysis has 
been performed with differently assigned obvious negative dipolar splittings and supposed 
splittings of 0 kHz (also under omission of the broad and badly resolved 10CF3-Phg PGLa). 
For 13CF3-Phg PGLa, however, a positive splitting was always retained. All combinations 
delivered qualitatively similar results, namely a surfacially aligned PGLa, but of different 
quality of fits (data not shown). The best fits with the lowest RMSD throughout the gel phase 
represented the common S-state and are depicted in Figure 4.14. 
The best fit orientational parameters are summarized in Table 4.8. A diagram with all 
tilt angles in dependence of the temperature is shown in Figure 4.16. 
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Figure 4.13 Best fit curves (left) and ? /?-diagrams (right) for PGLa alignments in the presence of 
magainin 2 (1/1) at high P/L ratio (1/50) in DMPC/DMPG (3/1) in the gel phase. Dashed lines indicate the 
angles ? and ? corresponding to the global minima. As described in the text, data represent the inserted state of 
two alignments. 
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Figure 4.14 Best fit curves (left) and ? /?-diagrams (right) for PGLa alignments in the presence of 
magainin 2 (1/1) at high P/L ratio (1/50) in DMPC/DMPG (3/1) in the gel phase. Dashed lines indicate the 
angles ? and ? corresponding to the global minima. As described in the text, data represent the surface state of 
two alignments. 
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Figure 4.15 Best fit curves (left) and ? /?-diagrams (right) for PGLa alignments in the presence of 
magainin 2 (1/1) at high P/L ratio (1/50) in DMPC/DMPG (3/1) in the fluid phase. Dashed lines indicate the 
angles ? and ? corresponding to the global minima. 
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Table 4.8 List of best-fit orientational parameters for PGLa in the presence of magainin 2 (1/1) at high 
P/L ratio (1/50) in oriented DMPC/DMPG (3/1) bilayers. Below 298 K two solutions correspond to the two 
sets of dipolar splittings found (Table 4.7). 
 
T [K] Smol Tilt [°] Rotation [°] RMSD [kHz] 
328 1,0 125 67 0,1 
323 1,0 125 67 0,1 
318 0,9 133 69 0,5 
313 0,8 137 69 0,4 
308 0,8 139 70 0,4 
303 0,7 141 71 0,4 
298 1,0 178 23 0,3 
 0,8 95 113 0,1 
293 0,9 144 74 0,3 
 0,8 96 113 0,2 
288 0,9 141 84 0,0 
 0,8 97 113 0,4 
 
At all temperatures for each set of triplets, one unique well-defined minimum can be found. 
PGLa in the presence of magainin 2 adopts a strongly tilted alignment in the fluid phase. The 
tilt can be found to decrease upon increase in temperature. However, at no temperature the 
alignment resembles the T-state as observed for PGLa alone. In the gel phase bilayer, at 
temperatures close to the phase transition, an upright inserted alignment can be found, more 
inclined as observed previously by 2H-NMR at ambient temperature (2.2.4.3). Corresponding 
populations of PGLa at lower temperatures exhibit smaller tilt angles. Surprisingly, in the gel 
phase a significant fraction of PGLa exhibits a surface alignment. For both alignment states 
below Tm, the order parameter S adopts values close to one, reflecting the restriction of 
peptide mobility in the gel phase of the lipid bilayer. The maximum value of 1,0 can be found 
for the inserted state with a tilt angle ? of close to 180° at Tm. Above 298 K, S reduces to 0,7, 
similar to PGLa alone in the T-state, indicating no large aggregates are being formed. Upon 
further elevation of temperature, an unexpected increase in Smol takes place, accompanied by 
a gradual decrease in tilt as observed in Figure 4.7. A jump in the tilt angle ? can be observed 
from 318 to 323 K. S adopts the maximum value of 1,0. It is noticeable that the azimuthal 
rotation angle ? retains a constantly small value throughout the whole fluid phase. A diagram 
showing all tilt angles as a function of temperature is displayed in Figure 4.16. 
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Figure 4.16 Temperature-dependence of PGLa tilt angle in presence of magainin 2 (1/1) in oriented 
DMPC/DMPG (3/1) bilayers at high P/L ratio (1/50). Data points are connected for an easier identification. 
Grey bar indicates main phase transition temperature (Tm) of the pure lipid mixture (according to Lewis 2005). 
 
Upon tilt of the sample by 90°, 19F-NMR spectra of 13CF3-Phg PGLa up to 298 K exhibit 
broad signals with negative nonresolved dipolar splittings. This line shape is expected for a 
superposition of signals from a surface-aligned and a membrane-inserted fraction of the 
peptide, both being restricted in their mobility. Just above 298 K dipolar splittings can be 
found to scale around the isotropic position. The scaling factor can only be estimated roughly, 
as spectra are not sufficiently resolved. However, the principal behaviour suggests rotational 
mobility of PGLa, here. Upon further elevation of temperature, an extension of signal to the 
high field side, towards and across the isotropic position, can be observed. Apparently, the 
complex behaviour of PGLa under these conditions as indicated so far, as well as poor 
resolution of spectra, unfortunately do not allow a detailed analysis. Since no obvious 
corresponding change in the spectral line shape of 13CF3-Phg PGLa at 0° tilt can be 
observed, the change may be attributed to the increase in S, i.e. the restricted mobility of the 
peptide. However, taking into account the evolution of the spectral line shapes of 9CF3-Phg 
and 10CF3-Phg PGLa at 0° tilt (Figure 4.11), this change may point towards a redistribution 
among two populations of peptide alignments. 
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Figure 4.17 Solid state 
19
F-NMR spectra of 13CF3-Phg PGLa in the presence of magainin 2 in oriented 
DMPC/DMPG (3/1) bilayers at high P/L ratio (1/50) at different temperatures at 0° (left column) and 90° 
(right column) tilt. Dipolar splittings at 90° tilt are estimated with an accuracy of 0,5 kHz. 
 
4.2.8 Temperature-dependent realignment of PGLa in the presence of magainin 
2 (1/1) at high P/L ratio (1/50) in multilamellar vesicles 
Solid state 19F-NMR spectra of PGLa in the presence of magainin 2 (1/1) at high P/L ratio 
(1/50) in multilamellar vesicles of DMPC/DMPG (3/1) at hydration of 60 % (v/w) are 
displayed in Figure 4.18. Dipolar splittings are summarized in Table 4.9. Spectra exhibit a 
temperature-dependent change in the line shapes in the range of 288 K to 328 K. 
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Figure 4.18 Solid state 
19
F-NMR spectra of CF3-Phg-labeled PGLa analogues (labeled position given on 
top of each column) in the presence of magainin 2 (1/1) in multilamellar vesicles of DMPC/DMPG (3/1) at 
high P/L ratio (1/50) at different temperatures. Due to experimental difficulties, some spectra are lacking. 
 
Spectra are far less resolved, dipolar splittings are much smaller compared to multilamellar 
vesicles with PGLa alone (4.2.6). Again, due to unresolved dipolar splittings, no 
determination of the peptide orientational parameters was performed. Up to 298 K all labeled 
PGLa analogues exhibit dipolar splittings close to -7 kHz. Above 298 K, i.e. in the fluid 
lamellar bilayer phase, spectra are significantly different. All labeled peptides exhibit small 
positive dipolar splitting of approximately +2 kHz just above Tm. For illustration, 14CF3-Phg 
PGLa as the most pronounced spectrum of that set at 303 K is expanded in Figure 4.19. Upon 
further elevation of temperature a slight change of spectral line shapes can be observed 
among all CF3-labeled peptides, except for 14CF3-Phg PGLa. Positive dipolar splitting 
persists in spectra of 14CF3-Phg PGLa throughout the whole temperature range. Spectral line 
shapes of 9CF3-Phg and 10CF3-Phg PGLa shift to an isotropic-like signal upon elevation of 
temperature to 328 K. Simultaneously 13CF3-Phg PGLa shows a gradual shift of line shape 
from positive to isotropic to negative dipolar splitting. 
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Table 4.9 Dipolar splittings for different CF3-Phg-labeled PGLa analogues in the presence of magainin 2 
(1/1) in DMPC/DMPG (3/1) multi-lamellar vesicles at high P/L ratio (1/50). Dipolar splittings from 303 K 
upwards are estimated with an accuracy of 0,5 kHz. 
 
T [K] ?FF [kHz] 
 I9 A10 I13 A14 
328 0 0 - 2,0 + 2,0 
323 0 n/a - 1,0 + 2,5 
318 + 0,5 + 1 0 + 2,0 
313 + 1,0 n/a 0 + 2,5 
308 + 1,5 + 1,5 0 + 2,5 
303 + 2,0 + 1,5 + 1,5 + 2,5 
298 - 7,4 - 7,5 - 7,2 - 7,2 
293 - 7,2 - 6,9 - 6,9 - 7,3 
288 - 7,2 n/a - 7,0 n/a 
 
Dipolar splittings in multilamellar vesicles indicate a gradual decrease in peptide tilt within 
the fluid lamellar lipid phase upon increase in temperature. Just above Tm, small positive 
dipolar splittings among all labeled analogues correspond to a tilted alignment of PGLa 
(4.2.5), corresponding to oriented samples in the presence of magainin 2 (4.2.7). The line 
shape of 14CF3-Phg PGLa in multilamellar vesicles throughout the whole temperature range 
above 298 K may be attributed to a tilted as well as a surface alignment (compare to Figure 
4.8 and 4.2.6). According to oriented samples with PGLa alone (4.2.5), changes of both the 
line shapes of 9CF3 and 10CF3-Phg PGLa to an isotropic and simultaneously of 13CF3-Phg 
PGLa to an isotropic and beyond to a positive dipolar splitting, are expected for a realignment 
from a tilted to a surface orientation. However, due to bad resolution, the spectral line shapes 
in the fluid lamellar lipid phase towards 328 K do not provide an indication of  a 
redistribution between two alignment states as it may be suggested in oriented samples in the 
presence of magainin 2. 
 
 
Figure 4.19 Spectrum of 14CF3-Phg PGLa at 303 K in multilamellar vesicles of DMPC/DMPG (3/1) at 
high P/L ratio (1/50) expanded from Figure 4.18. Dipolar splitting is estimated with an accuracy of 0,5 kHz. 
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4.3 Discussion 
In this part of the study, the structure and orientation of PGLa in synthetic lipid bilayers, 
alone and together with magainin 2 as a synergistic pair, was analyzed as a function of lipid 
phase and temperature. 
To obtain orientational constraints, four differently labeled CF3-Phg PGLa analoga 
were systematically analyzed in fully hydrated macroscopically aligned samples composed of 
DMPC/DMPG (3/1) at a high P/L ratio of 1/50 in absence or presence of equimolar amount 
of magainin 2. PGLa was modeled as a rigid regular ?-helix (Glaser 2004) allowing the 
calculation of the orientational state and the overall mobility of the PGLa peptide. Results 
were subsequently compared to data from corresponding multilamellar vesicles at higher 
hydration. 
In previous studies, PGLa alone in synthetic lipid bilayers (DMPC or DMPC/DMPG) 
at ambient temperature could be demonstrated to undergo a concentration-dependent 
realignment from a flat surface-bound state (S-state) at low (1/200) P/L ratio to a tilted 
alignment (T-state) at high (1/50) P/L ratio (Glaser 2005; Glaser 2004; Tremouilhac 2006b; 
Strandberg 2006). In both alignment states the peptide rotates fast around the membrane 
normal. In the S-state, the  peptide was suggested to represent a monomeric state. At a tilt 
angle ? of approximately 100° and an azimuthal rotation angle ? of approximately 115°, the 
hydrophobic lysine residues are arranged towards the aqueous surrounding. For the T-state, 
the formation of antiparallel homodimers was proposed, with the C-termini of both helices 
immersing into the hydrophobic core of the membrane at a ? of approximately 125° and a ? 
of approximately 110°. 
Only in the presence of magainin 2 at equimolar ratio at high P/L ratio (1/50), a 
motionally restricted, inserted peptide (I-state) with a tilt angle of approximately 160° could 
be observed at ambient temperature (Tremouilhac 2006a). 
 
Overall, lipids in macroscopically aligned samples were well-oriented to an extent of usually 
above 80 % as determined upon integration of 31P-NMR spectra. Spectra of multilamellar 
vesicles showed a typical spectrum for spherically distributed lipids in a lamellar bilayer 
phase. Both observations prove the compatibility of a lamellar bilayer with the presence of 
PGLa or PGLa/mag 2 even at a high P/L ratio of 1/50. No indication of significant curvature 
stress or disruption of the bilayer integrity was observed. 
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In the present study, PGLa was shown for the first time to adopt all three alignment states (S, 
T and I) on its own, depending on the temperature and the lipid phase. All three states could 
be determined very accurately, as assessed by the corresponding RMSD values. 
In the lipid gel phase, PGLa adopts an upright inserted state (I-state) with a ? of 
approximately 170°. Due to this upright orientation, a broad range of values for ? will give a 
good fit, as ? will become undefinable in a perfectly upright orientation of the helix. In the 
fluid phase just above Tm, an oblique alignment (T-state) with a helix tilt angle ? of 
approximately 130° was found, changing discretely to approximately 100° (S-state) upon 
further elevation of temperature to 318 K and above. The azimuthal rotation angle retains a 
value of approximately 110° for both the S- and the T-state, and in accordance with the 
amphipathicity of the peptide helix places the positively charged lysine residues towards the 
aqueous surrounding. 
In gel phase bilayers, the absence of rotational diffusion of PGLa, as determined by 
90° tilt of samples, and an order parameter Smol adopting high values of approximately 0,9 to 
1,0, reflect the restricted mobility of PGLa in the I-state. In fluid bilayers, an order parameter 
Smol of approximately 0,6 to 0,7 can be found for both the T- and the S-state. The high 
rotational mobility of PGLa excludes the formation of large peptide aggregates in this case. 
The realignment of PGLa from the I- to the T-state appears to be related to the change 
of the lipid phase. A relatively rigid membrane in the gel phase, containing local defects, 
suggests to facilitate an insertion of PGLa. In the fluid phase above 318 K, during the 
transition from the T-state to the S-state, two distinct populations of peptide appear to exist. 
They rather represent a switch than a shift between both alignments, presumably effected by 
enhanced kinetic energy of the system breaking the supposed homodimers. 
Assuming that the 21 residue-long PGLa forms an ?-helix with 1,5 Å distance per 
residue (Tremhouilhac, 2007), upon adopting the I-state it will obtain an effective length 
across the membrane of approximately 31 Å according to x = 21*1,5Å* cos? . Hence, the 
peptide should match the length of the hydrophobic region of the DMPC/DMPG bilayer. This 
can be estimated to be approximately 30 Å upon determination of the hydrocarbon length of 
gel phase DMPC bilayers (Tristam-Nagle, 2002). 
High values of close to 1,0 for the order parameter in the I-state, indicate a rigid 
structure, supporting the presumption that the inserted PGLa helices might assemble into 
higher oligomers. Contact of the charged residues with the hydrophobic core of the 
membrane may be avoided by arranging the peptides into proposed transmembrane pores 
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with the hydrophobic residues facing the surrounding membrane core and the charged 
residues lining a water-filled interior of the channel (2.2.3). 
The three different alignment states observed for PGLa in oriented samples in 
dependence of temperature and lipid phase, are schematically illustrated in Figure 4.20. 
 
 
Figure 4.20 Illustration of the three different distinct alignment states identified for PGLa in oriented 
samples in dependence of temperature and lipid phase. In the lipid gel phase, PGLa is inserted almost 
upright (I-state), lacking rotational mobility. It is presumed, that homodimers arrange to form larger assemblies 
with an aqueous interior (pore structure). Just above the phase transition temperature, PGLa adopts a tilted 
alignment (T-state), supposedly as homodimers. Upon increase in temperature, these dimers are no longer stable 
and disassemble into monomers, which in accordance with their amphipathicity align on the surface of the 
membrane (S-state). 
 
In multilamellar vesicles, no determination of orientational parameters comparable to 
macroscopically aligned bilayers was performed, due to poorly resolved dipolar splittings. 
Hence, data were interpreted qualitatively, and results will be discussed solely in comparison 
to the alignment states found for PGLa in macroscopically aligned bilayers and to findings 
reported previously. 
For PGL at a high P/L ratio (1/50) in fluid phase multilamellar vesicles, in principle 
the same realignment as in oriented samples could be confirmed, from the T-state just above 
Tm to the S-state at elevated temperature. However, the realignment appeared to be a rather 
continuous event, instead of the expected distinct switch, as spectra showed a gradual change 
of line shapes and dipolar splittings with increasing temperature. 
Previously, the hydration of a sample was shown to influence the realignment with 
regard to the threshold concentration for the S-T transition and the range for the full transition 
(Tremhouilhac 2006b). The influences due to hydration were interpreted in terms of bulk 
water providing a reservoir for free peptide molecules in equilibrium with membrane-bound 
peptide species. In detail, the amount of positively charged amphiphilic peptide molecules 
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that a membrane can accomodate before electrostatic repulsion between peptides molecules 
leads to an equilibrium with the bulk water, depends on the amount of negative charge in the 
lipid bilayer. In fully hydrated oriented samples with virtually no bulk water phase, the 
affinity of the peptide to the membrane does not play a significant role, but the peptide will be 
bound to the membrane completely (Afonin 2003b). For instance, in fully hydrated 
multilamellar vesicle samples purely of zwitterionic DMPC, more peptide molecules are 
needed in the sample, i.e. a higher P/L ratio, compared to oriented bilayers of DMPC or to 
corresponding samples composed of DMPC/DMPG, to accumulate sufficient peptide 
molecules in the membrane bilayer to trigger the switch from the S- to the T-state, as 
significant amount of peptide escapes into the bulk water. In particular, in multilamellar 
vesicles composed of the net uncharged lipid DMPC at a high P/L ratio expected to arrange 
PGLa in the T-state, by 2H-NMR spectroscopy an atypical intermediate alignment between 
the S- and T-state was found (Tremhouilhac 2006b). It was rationalized as a fast exchange of 
peptides between the S-state and the T-state. In multilamellar vesicles composed of DMPC 
and the net negatively charged lipid DMPG, however, the decisive P/L ratios of 1/50 and 
1/200 resulted in the expected T- and S-state, respectively. 
Concerning the results of this study, it may thus reasonably be assumed that 
temperature, in addition to the previously determined factors (peptide concentration, lipid 
charge and hydration level), shifts the S-T equilibrium in multilamellar vesicles, and the 
observed spectra represent the averages of varying ratios of both alignment states. 
In accordance with data from oriented samples, there is evidence that the peptide also 
adopts an I-state in multilamellar vesicles in the lipid gel phase. However, as a result of the 
above described properties of the I-state, this alignment state cannot be confirmed 
unambiguously in this type of model membrane. The spread of orientations adopted by PGLa 
in the I-state in vesicles and the associated restricted rotational mobility, result in a spectrum 
similar to unoriented peptide. In fact, any immobilized peptide spherically distributed as in 
vesicles will result in a spectrum similar to unoriented peptide. 
 
As demonstrated above for PGLa alone, in oriented samples in the presence of magainin 2, 
the peptide was shown to realign in dependence of temperature and lipid phase. However, the 
situation is far more complex here. 
 In gel state bilayers, clear coexistence of two populations of PGLa at about equal 
amounts of peptide molecules could be identified. One population resides in a surface 
alignment, with the approximate angles ? and ? being 95° and 115°, respectively. These 
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angles correspond to the S-state as observed for PGLa alone, however, restricted rotational 
diffusion and peptide wobble are indicated by broad unresolved lines upon 90° tilt of samples 
and high order parameter values close to 1,0. The second population of PGLa was shown to 
reside in an I-state, adopting the most pronounced upright orientation at ? being 
approximately 180° around the phase transition of the lipid bilayer. The corresponding 
populations at lower temperatures adopt tilt angles of aproximately 145°. Despite the fact that 
these tilt angles are slightly lower than even previously found for the I-state, all these 
alignments are termed I-state here, as they are all deeply immerged into the hydrophobic core 
of the membrane and are motionally restricted, thus suggesting the assembly of 
transmembrane pores. For the observed I-state of PGLa in the presence of magainin 2 around 
phase transition, the peptide will obtain an effective length across the membrane of 
approximately 32 Å, being in accordance with the hydrophobic length of the bilayer (as 
described above). 
 In the fluid phase upon increase in temperature up to 318 K, in the presence of 
magainin 2, PGLa was found to be strongly inclined at a continuously decreasing tilt angle 
from approximately 140° to 130°. Compared to the T-state adopted by PGLa alone, the 
peptide helix is rolled by about 40° in the membrane plane, obtaining an azimuthal rotation 
angle of approximately 70° throughout. As a result, the hydrophobic face of the helix is rather 
placed on one side to the aqueous surrounding, and three of four lysine residues may be 
expected to point straight out of the membrane plane. PGLa is rotationally mobile at lower 
temperatures, as it was demonstrated by measurements at 90° tilt. Hence, the formation of 
larger aggregates could be excluded there. However, a rapid increase upon elevation of 
temperature and decrease in tilt could be observed. 
The highly tilted and rolled PGLa helix is consistent with previous studies, proposing 
the formation of parallel heterodimers of PGLa and magainin 2 (Matsuzaki 1998b; Hara 
2001). These dimers were suggested to be stabilized by salt bridges between the charged 
residues Lys-19 of PGLa and Glu-19 of magainin 2 (Tremhouilhac 2006a). The azimuthal 
rotation angle actually observed here, may also suggests an interaction between the proximate 
Lys-15 of PGLa and Glu-19 of magainin 2. The presumed heterodimer would allow the 
peptides to immerge more deeply into the membrane as compared to the proposed PGLa 
homodimer. 
A transition from this strongly inclined tilt to another distinct alignment state could be 
observed above 318 K, together with a surprising jump in the order parameter. This event 
suggests an involvement of a similar mechanism as the dimer-monomer transition described 
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above for PGLa alone. This second state in the fluid phase was determined as a tilted 
alignment with a lower inclination. However, due to the complexity of temperature-dependent 
behaviour of PGLa in the presence of magainin 2, an unambiguous determination of that 
alignment state (4.2.7) was not possible with the present data. It should therefore be noted, 
that apart from this tilted state, a different approach suggested a redistribution between above 
described strongly tilted and a surface-aligned population of PGLa. However, the indication 
of a peptide behaviour comparable to PGLa alone is identical in either interpretation. 
The different alignment states observed for PGLa in oriented samples in dependence 
of temperature and lipid phase, are schematically illustrated in Figure 4.21. 
 
 
Figure 4.21 Illustration of the different alignment states identified for PGLa (grey) in the presence of 
magainin 2 (green) in a 1/1 molar ratio in oriented samples in dependence of temperature and lipid phase. 
The behaviour of magainin 2 is not confirmed. In the lipid gel phase, PGLa is inserted almost upright (I-state), 
lacking rotational mobility. The largest inclination is adopted around phase transition. It is presumed, that 
heterodimers of PGLa/magainin 2 arrange to form larger assemblies with an aqueous interior (pore structure). A 
coexisting immobilized surfacially aligned population is indicated aside (S´-state). Just above the phase 
transition, PGLa adopts a strongly tilted alignment, supposedly as heterodimers together with magainin 2 
(termed T-state, as it is the corresponding alignment to PGLa alone). Upon increase in temperature, PGLa was 
observed to realign, presumably adopting a lower inclination (T`-state). However, the redistribution between the 
T-state and a surface alignment (comparable to PGLa alone) cannot be excluded. 
 
For multilamellar vesicles with PGLa in the presence of magainin 2, the corresponding 
considerations as for PGLa alone are applicable. No determination of orientational parameters 
comparable to macroscopically aligned bilayers was performed, especially as spectra in this 
case additionally exhibited less resolved lines due to lower rotational mobility of the peptide. 
However, in fluid phase multilamellar vesicles as in the corresponding oriented samples, the 
signs of the broad spectral lines obviously display a comparable tilted alignment of PGL in 
the presence of magainin 2 just above Tm, and a subsequent realignment with decreasing tilt 
upon increase in temperature. A surface alignment is suggested at elevated temperature. As in 
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multilamellar vesicles with PGLa alone, the realignment appears to be a rather continuous 
event. As above in the gel phase, the inserted upright alignment cannot be confirmed 
unambiguously in this type of membrane model. 
 
In summary, PGLa in macroscopically aligned synthetic lipid bilayers was demonstrated to 
exhibit a similar principle behaviour in the presence or absence of equimolar amounts of 
magainin 2, showing an upright inserted alignment in the gel phase, a tilted alignment in the 
fluid phase, and a further distinctly different alignment at elevated temperature. However, in 
the presence of magainin 2, a coexisting surface alignment was observed in the gel phase. 
Furthermore, in the fluid phase the PGLa helix inclination was shown to be markedly 
increased in the presence of magainin 2. Despite this complex behaviour, the presented results 
are well in accordance with previous studies. Previous NMR studies conducted at ambient 
temperature focused primarily on the variation of the parameters P/L ratio, lipid composition 
or hydration status (Glaser 2005; Tremouilhac 2006b), whereas the focus of this study was on 
temperature and lipid phase. The results of this study may structurally explain the different 
functional activities performed by PGLa alone and together with magainin 2 as a synergistic 
pair. They may as well exert considerable implications on the activity of AMPs in native cell 
membranes, in general. 
 Previous studies reported the functional synergism of PGLa/magainin 2 mixtures 
(Westerhoff 1995) and described the membrane lytic activity being maximal at an equimolar 
ratio of both peptides (Matsuzaki 1998b; Hara 2001; Nishida 2007). Synergism was attributed 
to the formation of parallel heterodimers, presumed to enable the synergetic pair to form 
pores at a faster rate as either peptide and being more stable than the transmembrane pores of 
PGLa (Ludtke 1996; Matsuzaki 1998b; Tremouilhac 2006a). This may at least partially be 
attributed to the observed larger inclination, presumably resulting in a deeper immersion in 
the membrane. However, neither for PGLa nor for PGLa/magainin 2 mixtures, such a pore 
structure has been observed, yet. PGLa in the presence of magainin 2 was only demonstrated 
to adopt an inserted alignment at ambient temperature (Tremouilhac 2006a). 
Transient pore formation, however, is consistent with the SMH model. Leakage by 
magainin 2 was observed to be maximal in the early stage of the peptide-lipid interaction 
(Matsuzaki 1995b). Accumulation of peptide molecules in the outer membrane layer is 
assumed to induce curvature strain in the membrane, presenting one of the driving forces for 
the translocation of peptide molecules across the bilayer and for the potential membrane 
perturbance. Once the equilibrium is reached, only the most stable situation for this high 
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peptide concentration might be observed. That supposedly might be a shallow tilt for pure 
PGLa or a more deeply immersed peptide in equimolar PGLa/magainin 2 mixtures. Despite 
the fact, that a transient I-state therefore might only be trapped, identified and investigated 
under conditions of oriented membranes in gel phase lipid bilayers, the basic tendency of 
PGLa to insert into lipid bilayers is obvious, be it alone or to a larger extent in the presence of 
magainin 2. 
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5 Preparation of cytoplasmic membranes for solid state NMR 
spectroscopy 
5.1 Materials and methods 
5.1.1 Instruments 
Autoclave Sanoclav Wolf (Geislingen, Germany) 
Autoclave Systec 2540 EL Systec (Wettenberg, Germany) 
Autoclave Varioklav 400 H+P Labortechnik (Oberschleissheim, Germany) 
Balance PB 3001 (accuracy (acc.) 0,1 g) Mettler Toledo (Greifensee, Switzerland) 
Balance analytic Sartorius (acc. 0,0001 g) Mettler Toledo (Greifensee, Switzerland) 
Balance M2P Sartorius (acc. 0,0001 mg) Mettler Toledo (Greifensee, Switzerland) 
Camera PowerShot G5 Canon (Japan) 
Centrifuge 3-18K 
    with Rotor 19776-H 
Sigma (Osterode am Harz, Germany) 
Centrifuge Avanti J-25 
    with Rotors JA14 and JLA-9.1000 
Beckman Coulter (Fullerton, CA, USA) 
Centrifuge Biofuge Pico Heraeus (Hanau, Germany) 
Centrifuge L8-60M Ultracentrifuge 
    with Rotor VTi65 
Beckman (Palo Alto, CA, USA) 
Culture flasks (50 ml; 1 l; 2 l) Schott Duran (Mainz, Germany) 
Diaphragm vacuum pump Vacuubrand (Wertheim, Germany) 
Glass tubes Schott Duran (Mainz, Germany) 
Incubator shaker model G25 New Brunswick Scientific (Edison, NJ, USA) 
Incubator shaker Innova 44 New Brunswick Scientific (Edison, NJ, USA) 
Laminar flow box Hera safe Heraeus Instruments (Stuttgart, Germany) 
Microscope Axioskop 40 Zeiss (Heidelberg, Germany) 
NMR spectrometer Avance 500 
    Probehead for 31P H/X/Y 
Bruker Biospin (Karlsruhe, Germany) 
Bruker Biospin (Karlsruhe, Germany) 
Oven B5042 Heraeus (Hanau, Germany) 
Pipette Reference 
    (0,5-10 ?l; 10-100 ?l; 100-1000 ?l) 
Eppendorf (Hamburg, Germany) 
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Pipettes Pipetus akku Pipetus (Eberstadt, Germany) 
Shaker Biometra (Goettingen, Germany) 
Shaker KS250 basic IKA Labortechnik (Staufen, Germany) 
Sonifier 250 Branson Heinemann (Schwäbisch Gmünd, Germany) 
Spectrophotometer Smart Spec Plus Bio-Rad (Hercules, CA, USA) 
Spectrophotometer Carey 1E Varian (Palo Alto, CA, USA) 
Tube sealer Beckman (Palo Alto, CA, USA) 
Vortex mixer Genie K-550-GE Bender & Hobein (Zurich, Switzerland) 
Water bath GFL Migge Laborbedarf (Heidelberg, Germany) 
5.1.2 Consumables 
Centrifuge tubes (15 ml; 50 ml) Sarstedt (Nuembrecht, Germany) 
Centrifuge tubes Quick-seal Polyallomer Beckman (Palo Alto, CA, USA) 
Cover glasses (20 mm) Roth (Karlsruhe, Germany) 
Cryo tube vials (1,8 ml) Nunc (Roskilde, Denmark) 
Cuvettes Sarstedt (Nümbrecht, Germany) 
Glass plates (18 x 7,5 x 0,08 mm) Marienfeld Laboratory Glassware (Lauda-
Königshofen, Germany) 
Glass slides Roth (Karlsruhe, Germany) 
Parafilm American National Can (Chicago, IL, USA) 
Pipette tips Sarstedt (Nümbrecht, Germany) 
Reaction tubes (0,5 ml; 1,5 ml; 2,0 ml) Sarstedt (Nuembrecht, Germany) 
Serological Pipettes (5 ml; 10 ml; 25 ml) Roth (Karlsruhe, Germany) 
Syringe needles Sterican Braun (Melsungen, Germany) 
Syringe (10 ml, 20 ml, 50 ml) Braun (Melsungen, Germany) 
5.1.3 Chemicals 
Ascorbate Merck (Darmstadt, Germany) 
Bacto tryptone Becton, Dickinson & Co (Sparks, MD, USA) 
CHCl3 Merck (Darmstadt, Germany) 
EDTA AppliChem (Darmstadt, Germany) 
Ethanol Roth (Karlsruhe, Germany) 
Glycerol Roth (Karlsruhe, Germany) 
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HCl 1 M Roth (Karlsruhe, Germany) 
H2SO4 98 % Merck (Darmstadt, Germany) 
K2SO4 Roth (Karlsruhe, Germany) 
Methanol Fischer Scientific (Leicestershire, UK) 
MgCl2 6H2O Roth (Karlsruhe, Germany) 
Mg(NO3)2 Aldrich (Steinheim, Germany) 
NaCl Fischer Scientific (Leicestershire, UK) 
Na2HPO4 AppliChem (Darmstadt, Germany) 
NaN3 Roth (Karlsruhe, Germany) 
NaOH Merck (Darmstadt, Germany) 
(NH4)6Mo7O24 4H2O Sigma (Steinheim, Germany) 
Silica gel Merck (Darmstadt, Germany) 
Tris Roth (Karlsruhe, Germany) 
5.1.4 Enzymes 
Lysozyme     Fluka (Buchs, Switzerland) 
DNase      AppliChem (Darmstadt, Germany) 
RNase      AppliChem (Darmstadt, Germany) 
5.1.5 Human erythrocytes 
Citrate-phosphate-dextrose-stabilized blood bags (CPD) (erythrocyte suspensions) were 
obtained from the blood bank of the municipal hospital (Karlsruhe, Germany). Opened bags 
were used on the same day only. 
5.1.6 Bacterial strains 
Micrococcus luteus ATCC 4698 was obtained from Marina Berditch from our group. A set of 
glycerol stocks (20 %) was freshly prepared prior to this study and was stored at -20 °C 
throughout.  
5.1.7 Software 
TopSpin 2.0 (Bruker) 
XWinNMR (Bruker) 
dmfit (Massiot 2002) 
Canon RemoteCapture 2.7.3.23 (2003) 
Cary WinUV 
Illustrator 10 (Adobe) 
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Excel 2004 for Mac Version 11 (Microsoft) 
Photoshop 7 (Adobe) 
Power Point 2004 for Mac Version 11 (Microsoft) 
Word 2004 for Mac Version 11 (Microsoft) 
5.1.8 Preparation of Erythrocyte ghosts 
Preparation of cell membranes from erythrocytes was performed with modified and adapted 
protocols published previously (Dodge 1963; Hanahan 1974). 
Human erythrocytes (35 ml) from CPD-stabilized blood bags were washed twice with 
10-fold excess of ice-cold 172 mM Tris (pH 7,6) (600g, 10 min, 4 °C) and once more in 2-
fold excess in a smaller tube (50 ml) to pack cells. To lyse erythrocytes, aliquots of packed 
cells (5 ml) were diluted 30-fold in ice-cold 9 mM Tris (pH 7,6) and agitated carefully (5 min, 
on ice). The cell membranes were collected (20000g, 70 min, 4 °C) and resuspended in the 
previous solution. After three further washings, membrane pellets of four erythrocyte aliquots 
were combined in 9 mM Tris (pH 7,6) containing 0,01 % NaN3, to prevent bacterial growth 
later, and washed twice more. The final washing step was performed in a smaller tube (50 ml) 
to reduce the extent of the pellet, as it was rather soft and difficult to handle. The final 
membrane sediment was translucent and light pink in colour. It was resuspended thoroughly 
by pipetting in about 5 ml of the latter solution and stored on ice for forthcoming soon use. 
5.1.9 Preparation of Micrococcus luteus membrane vesicles 
Preparation of cell membranes from Micrococcus luteus ATCC 4698 was performed with 
previous protocols, modified and adapted concerning growth, lysozyme treatment and 
washing of membrane vesicles (Prasad 1965; Pakkiri 2004; Powell 1975; Hrafnsdottir 1997). 
M. luteus was grown in 800 ml of basal medium (10 g Bacto peptone, 5 g NaCl in 
1000 ml double-distilled water, pH 7,5) contained in 2000 ml flasks. Flasks were shaken at 
220 rpm at 37 °C. Cells were harvested after the log phase in the late growth phase (20-24 h, 
A650 = 3-4) by centrifugation (6000g, 15 min, 4 °C). The cell pellets were washed twice in 
(ca. 600 ml) 0,9 % NaCl solution (0 °C)  and then once in (ca. 50 ml) 50 mM Tris (pH 7,5, 
room temperature), containing 10 mM EDTA and 30 mM MgCl2. Wet weight was 
determined, and the cells were resuspended thoroughly at 200 mg wet weight per 1 ml of the 
previous solution (ca. 35 ml). Lysozyme (1 mg/ml), DNase and RNase (10 ?g/ml each) were 
added, and the cells suspension was incubated over night (12-14 h) at room temperature with 
careful agitation. During the incubation the viscosity markedly increased first, then the 
suspension became homogenous and fluid. 
 76
The suspension was diluted 20-fold with ice-cold 9 mM Tris (pH 7,6) and agitated 
carefully (5 min, on ice). The cell suspension was centrifuged (700g, 30 min, 4 °C) to remove 
unbroken and unlysed cells. The supernatant was removed and centrifuged (26000g, 150 min, 
4 °C) to collect membrane vesicles. The previous sediment of unlysed cells was suspended, 
agitated and centrifuged again, and the supernatant was used to resuspend the previous 
membrane vesicles. The combined membrane vesicles were sedimented as above, the 
membrane pellets were resuspended (ca. 160 ml) and sedimented again. Membrane vesicles 
were washed twice more in 9 mM Tris (pH 7,6) containing 0,01 % NaN3. The final 
membrane sediment was transparent and intense amber in colour. It was resuspended 
thoroughly by pipetting in about 6 ml of the latter solution for NMR experiments on vesicle 
suspensions or in double-distilled water for oriented membranes, and stored on ice for 
forthcoming use. 
5.1.10 Extraction of lipids 
Lipids were extracted according to previously published protocols with some modifications 
(Folch 1957; Bligh 1959) 
An aliquot of the membrane suspension (typically 100 ?l) was homogenized by 
repeated vortexing and sonication in 20-fold excess of CHCl3/methanol (2/1). Four aliquots of 
0,9 % NaCl solution were added, and the previous procedure was repeated. The mixture was 
left standing for about 20 min at room temperature and was then separated into two phases by 
centrifugation (9000 g, 10 min, 4 °C). The lower organic phase (typically about 1200 ?l) is 
the total pure lipid extract. A phosphate assay was usually performed on the same day. Lipid 
extracts were stored at -80 °C when not immediately used. 
5.1.11 Phosphate assay 
The amount of phospholipids was determined from lipid extracts as inorganic phosphate 
content after ashing of organic material according to previously published protocols with 
some modifications (Ames 1966; Ames 1960). 
Aliquots of the lipid extracts (typically 50, 100 and 200 ?l) were mixed in Duran glass 
tubes with 50 ?l of Mg(NO3)2 in ethanol. The mixture was evaporated to dryness over a 
strong flame with rapid shaking and further heating until the fumes had disappeared. That 
procedure resulted in the ashing of phospholipids to deliver inorganic phosphate. After the 
tube had cooled, 300 ?l of 1 M HCl was added. The tube was capped with a marble and 
heated in a water bath (95 °C) for 20 minutes to hydrolyze to inorganic phosphate any 
pyrophosphate formed in the ashing procedure. 700 ?l of freshly prepared 10 % ascorbic acid 
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plus molybdate in H2SO4 in a ratio of 6/1 was added to the tube. The mixture was incubated 
for 20 minutes at 45 °C to develop a blue colour complex. Absorbance was read at 820 nm 
against a blank containing water. Calibration was done with a series of Na2HPO4 dilutions in 
water, to which ascorbate/molybdate was added and incubation at 45 °C was performed. 
5.1.12 Preparation of vesicle suspension samples 
0,5 to 2,5 ml of pure membrane suspension was transferred to a polyallomer centrifuge tube, 
filled up with 9 mM Tris (pH 7,6) containing 0,01% NaN3, heat-sealed and centrifuged in a 
vertical rotor (360000g, 19-21 h, 4 °C). The supernatant was carefully removed with a syringe 
and discarded. The membrane pellet was transferred with a spatula into a small polyethylene 
bag which was heat sealed and packed into a second bag. The sample was stored at 4 °C until 
impending use. 
5.1.13 Preparation of oriented samples 
Membrane suspensions were washed once more with 10-fold excess off double-distilled 
water, containing 0,005 % NaN3 (18000g, 90 min, 4 °C) (typically) to remove salts, which 
delay drying of samples and thereby enhance microbial contamination. Thin glass plates (18 
mm x 7,5 mm x 0,08 mm) were washed with methanol and dried under vacuum for 2 h. 
Aliquots of the membrane suspension (about 100 ?l) were deposited onto the glass plates (up 
to 18 plates in total), dried over silica gel for 2-3 d, stacked, covered with an additional glass 
plate and hydrated at 96 % relative humidity (over a saturated solution of K2SO4) at 46 °C for 
about 36 h. The stacks were wrapped in parafilm and a polyethylene foil. Samples were 
stored at -20 °C until impending use. 
5.1.14 Solid state 
31
P-NMR spectroscopy of cytoplasmic membranes 
31P-NMR measurements were carried out on a widebore Bruker Avance 500 MHz NMR 
spectrometer (Bruker Biospin, Karlsruhe, Germany) at a transmitter frequency of 202,5 MHz. 
A 1H/X/Y probehead with interchangeable flat-coils for horizontal or vertical alignment of 
samples was used. Oriented samples were aligned with the lipid membrane normal either 
parallel or perpendicular to B0. 
31P-NMR spectra were aquired at 308 K. Typically 1H-
decoupled Hahn-echo spectra were recorded with 90° pulse durations of 6 ?s, relaxation 
delays of 2 s and inter-pulse echo delays of 30 ?s. Number of scans was typically 1024 for 
oriented cytoplasmic membranes and 2048 for vesicle suspensions. Spectra were referenced 
against externally measured 85% H3PO4 solution aquired at 308 K which was set to 0 ppm. 
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5.2 Results 
5.2.1 Erythrocyte ghosts 
Preparations of erythrocyte ghosts could be monitored by optical microscopy throughout the 
whole process (Figure 5.1). 
 
 
Figure 5.1 Representative photograph of 
erythrocyte ghosts after lysis of cells and repeated 
washings. 
 
As the cytoplasm of erythrocytes comprises almost entirely of hemoglobin, the hemoglobin 
content (per cell dry weight) could be used as a measure for the purity of a preparation. 
Residual hemoglobin in erythrocyte ghosts was determined by KCN (Baake 1994) in 
preliminary experiments to adopt the method and later to control the consistency of the 
method. Cells contained well below 10 % of residual hemoglobin in both cases (data not 
shown). 
 
Resulting membrane suspensions typically contained 4 to 8 mM of lipid phosphorus as 
determined by phosphate assay (data not shown). From each preparation process, typically a 
membrane suspension volume of 5 ml was available. 
5.2.2 Bacillus luteus cytoplasmic membranes 
Initially, for preparations of bacterial cytoplasmic membranes, Bacillus subtilis ATCC 6633 
was employed. To access the membranes of B. subtilis, degradation of the cell wall by 
lysozyme and/or disruption of cells by French pressure cell or by sonification was performed. 
None of these methods delivered satisfying vesicle preparations in sufficient yield for solid 
state NMR spectroscopy. Membranes could be traced by the enzyme succinic acid 
dehydrogenase (SDH) of the respiratory chain, residing in the cell membrane of B. subtilis 
(results not shown). According to this, the largest amount of membrane material appeared to 
be lost during the first step of slow centrifugation. Optical microscopy observations showed 
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high numbers of unlysed cells in the sediment (pictures not shown). Apart from the low 
sensitivity of B. subtilis to lysozyme, the major difficulty became obvious in 31P-NMR 
spectroscopy of membrane vesicle suspensions, employed to control the quality of the 
preparations. Membrane preparations were homogenous in microscopy (pictures not shown), 
but 31P-NMR spectra suffered from a dominating signal component around the isotropic 
position (Figure 5.2). This component could not be removed upon further washing of 
membranes, hence was presumed to be membrane-related, and assigned to the phosphorus-
containing teichoic acids (LTA), abundant in B. subtilis. 
 
 
Figure 5.2 
31
P-NMR spectrum of unoriented 
membranes of B. subtilis. The spectrum is 
dominated by a large signal around the isotropic 
position. The signal of phospholipids in a 
lamellar lipid phase in vesicles can be identified 
underneath. 
 
5.2.3 Micrococcus luteus cytoplasmic membranes 
The enzyme SDH of the respiratory chain was employed as a marker enzyme in preparatory 
experiments to monitor small-sized cytoplasmic membrane vesicles of Micrococcus luteus 
ATCC 4698 (Figure 5.3). The largest amount of membrane material appeared to be lost 
during the first step of slow centrifugation (results not shown). Optical microscopy 
observations showed high numbers of unlysed cells in the sediment (pictures not shown). 
However, to achieve purer membrane preparations, these fractions were discarded. As 
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monitored by SDH, membrane vesicles from the supernatant could be recovered in each 
washing step. 
 
 
Figure 5.3 Representative photograph of M. luteus 
membrane vesicles after lysis of cells and repeated 
washings. 
 
Since teichoic acids are absent in M. luteus envelopes, and the major membrane-related 
phosphorus-containing components are phospholipids, solid state 31P-NMR spectroscopy was 
suited well to track the removal of residual cytoplasmic content in successive steps of a 
membrane preparation. In M. luteus membrane preparations, signals from phosphorous-
containing components other than from phospholipids in the fluid lamellar lipid phase, 
disturbed the spectrum initially, but were possible to reduce upon additional lysis and 
sedimentation (Figure 5.4) and were apparently absent in the final membrane vesicles (Figure 
5.5 upper right). 
 
 
Figure 5.4 
31
P-NMR spectra of unoriented 
membranes of M. luteus. Upper spectrum 
obtained after initial hypotonic lysis of M. luteus 
cells and first sedimentation of membranes. Lower 
spectrum obtained after second lysis and 
sedimentation. The spectrum of the final 
membrane vesicles is shown in Figure 5.5. 
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Resulting membrane suspensions contained typically 1 to 2 mM of presumable lipid 
phosphorous as shown by phosphate assay (data not shown). From each preparation process, 
typically a membrane suspension volume of 6 ml was available. 
5.2.4 Solid state 
31
P-NMR spectroscopy of cytoplasmic membrane preparations 
Representative solid state 31P-NMR spectra of pure membranes of erythrocytes and M. luteus 
as vesicle suspensions as well as oriented samples at 308 K are shown in Figure 5.5. CSA 
parameters are listed in Table 5.1. 
 
 
Figure 5.5 
31
P-NMR spectra of unoriented (upper) and oriented (middle and lower row) 
membranes of erythrocytes (left column) and M. luteus (right column) at 308 K. Spectra of 
oriented samples aquired at 0° (middle row) and 90° (lower row) tilt. 
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Table 5.1 Characteristic CSA parameters [ppm] extracted from spectra of unoriented and oriented 
membranes of erythrocytes and M. luteus in Figure 5.5. 
 
  Erythrocytes M. luteus 
Vesicle suspension ??? ???  35 27 
Oriented sample (0°) ???  23 17 
Oriented sample (90°) ??  -12 -9 
???(0°) ??? (90°)  35 26 
 
Suspensions of cell membranes show broad powder spectra with shoulders at +23 ppm and -
12 ppm for erythrocytes and +17 ppm and -9 ppm for M. luteus. The line shapes correspond 
to spherically distributed phospholipids rotating freely along their longitudinal axis, i.e. lipids 
within a fluid phase membrane (see section 2.3.4). A small isotropic-like component of 
varying intensity could be observed non-systematically among different freshly prepared 
samples. 
Oriented samples of erythrocytes aligned at 0° and 90° tilt of their membrane normal 
with respect to the magnetic field give rise to signals with well-defined peaks around +23 
ppm and -12 ppm with a width of 6 and 7 ppm, respectively, demonstrating good alignment 
of phospholipids. No separate signals of individual types of phospholipids in erythrocyte 
membranes are resolved. Oriented samples at 0° and 90° tilt exhibit isotropic signals, 
coinciding with isotropic signals observed in spectra of unoriented  membranes. 
Oriented samples of M. luteus give rise to signals at approximately +17 ppm as the 0° 
edge and at -9 ppm as the 90° edge of the spectrum, demonstrating alignment of 
phospholipids. No separate signals of individual types of phospholipids are resolved. Signal 
widths of 24 and 15 ppm are significantely larger as in oriented erythrocyte membranes. As in 
oriented erythrocyte membranes, isotropic signals with low intensity are present. 
Both types of membranes show good match of CSA values from unoriented and 
oriented samples (Table 5.1). 
31P-NMR spectra of cytoplasmic membranes of erythrocytes and Micrococcus luteus 
together with peptide were comparable to spectra of pure membranes shown above (Figure 
5.5). 
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5.3 Discussion 
The preparation of erythrocyte ghosts is well-established. Some solid state NMR 
investigations have already been performed on erythrocyte membrane vesicles (McLaughlin 
1975; Yeagle 1982) and even on erythrocyte membranes, aligned by an isopotential spin-dry 
ultracentrifugation technique (Gröbner 1997). Cytoplasmic membrane preparations of 
Bacteria, however, have apparently never been employed in solid state NMR spectroscopy. In 
this part of the present study, cell membranes of human erythrocytes and the Gram-positive 
bacterium M. luteus were prepared as vesicle suspension and oriented bilayers, for solid state 
NMR structural studies of an AMP in an environment closer to the in vivo situation than any 
previously used membrane systems. 
Membranes were prepared by hypotonic lysis of cells, followed by extensive washing 
of vesicles. The quality of the membrane preparations was monitored directly by 31P-NMR 
spectroscopy of vesicles. Membrane preparations exhibited the characteristic line shape for a 
lamellar phase in vesicle suspensions and showed orientation of phospholipids in 
macroscopically aligned bilayers, thus providing a situation utilizable to study PGLa. The 
rather high mosaic spread of the oriented lipids on glass slides was assigned largely to the 
complex lipid composition and high amount of protein in cell membranes. These effects have 
to be more pronounced in the M. luteus membranes, as they contain 70 to 80 % of proteins, 
compared to roughly 50 % in erythrocytes membranes. M. luteus membranes indeed 
exhibited spectra with significantly more inhomogenities and a far larger mosaic spread as in 
erythrocytes, whose spectra were smooth and peaked. Yet, it should also be considered that 
preparations of M. luteus membranes consist of much smaller vesicles, whereas erythrocyte 
preparations delivered ghosts as large as the original cells. An isotropic component 
observable in both types of oriented samples could be due to residual inorganic phosphorus 
after washing, or a fraction of non-bilayer lipid phase like micelles or a cubic phase. Since 
this was only a minor component in the spectra, it was not further investigated. However, 
these isotropic signals were empirically found to be useful as an internal reference and as an 
indicator on the hydration status of a sample. They are comperatively sharp in freshly 
prepared samples, but were found to broaden, decrease or vanish during long measurements 
upon heating. This was attributed to the drying of a sample, as the initial isotropic signal 
could be restored after rehydration of a sample. 
Initial attempts on B. subtilis delivered unsuitable material, presumably not in view of 
the membranes themselves, but with regard to the 31P-NMR spectrum employed for control, 
as spectra of phospholipids were dominated by some large isotropic compount. Since this 
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component was not removable by washing and therefore obviously membrane-bound, it 
presumably originates from teichoic acids, which are known to be abundant in the envelope 
of most Gram-positive bacteria including B. subtilis. M. luteus, in this respect, poses a lucky 
exception, as its envelope is not only devoid of teichoic acids, but also of other phosphorus-
containing polymers. Instead, it contains the functionally analogous and phosphate-free 
lipomannan, which is also not removable even by extensive washing (Pless 1975). 
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6 Solid state NMR investigations of PGLa in cytoplasmic 
membranes 
6.1 Materials and methods 
Instruments, consumables, chemicals and other materials used below are described in 4.1 and 
5.1. Samples were prepared with erythrocyte ghosts or M. luteus membrane vesicles as 
obtained in 5.1.8 and 5.1.9, respectively. 13CF3-Phg PGLa was applied to cytoplasmic 
membrane preparations at the desired P/PL ratio (peptide to phospholipid ratio) on the basis 
of the amount of phospholipids determined in 5.1.11. 
6.1.1 Preparation of vesicle suspension samples 
The appropriate amount of peptide (about 0,2-0,6 mg) was dissolved in 9 mM Tris (pH 7,6) 
containing 0,01 % NaN3 (typically 1-2 ml) by thorough vortexing and sonication. An 
appropiate volume of membrane vesicle suspension (about 0,5-2,5 ml) was added. The 
suspension was incubated overnight (14-16 h) at room temperature with careful agitation, 
then transferred to a polyallomer centrifuge tube, filled up with above Tris buffer, heat-sealed 
and centrifuged in a vertical rotor (360000g, 19-21 h, 4 °C). A sample of the supernatant was 
used for 19F-NMR spectroscopy in solution to ensure that the peptide was in the membrane 
pellet. The membrane pellet was transferred with a spatula into a small polyethylene bag 
which was heat sealed and packed into a second bag. The sample was stored at 4 °C until 
impending use. 
6.1.2 Preparation of oriented samples 
Prior to the addition of peptide, membrane suspensions were washed once more with 10-fold 
excess of double-distilled water, containing 0,005 % NaN3 (18000g, 90 min, 4 °C) (typically) 
to remove salts, which delay drying of samples and thereby enhance microbial contamination. 
The appropiate amount of peptide (typically 0,1-0,5 mg) was dissolved in double-distilled 
water (about 40 ?l) by thorough vortexing and sonication. An appropiate volume of the 
membrane vesicle suspension (typically 0,9-1,8 ml) was added. The suspension was 
incubated overnight (about 14 h) at room temperature with careful agitation. Thin glass plates 
(18 mm x 7,5 mm x 0,08 mm) were washed with methanol and dried under vacuum for 2 h. 
Aliquots of the membrane suspension with peptide (about 100 ?l) were deposited onto the 
glass plates (up to 18 plates in total), dried over silica gel for 2-3 d, stacked, covered with an 
additional glass plate and hydrated at 96 % relative humidity (over a saturated solution of 
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K2SO4) at 46 °C for about 36 h. The stacks were wrapped into parafilm and a polyethylene 
foil. Samples were stored at -20 °C until impending use. 
6.1.3 Solid state NMR spectroscopy 
31P-NMR spectroscopy was carried out as described in 5.1.14. 19F-NMR was performed as 
described in 4.1.9, except for the higher number of scans being 10000 to 60000 for samples at 
high P/PL ratios and 20000 to 100000 for samples at low P/PL ratios. 
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6.2 Results 
The given ratio P/PL denotes the ratio of peptide (P) to phospholipid (PL) as determined by 
the assay for inorganic phosphate. 
After incubation of membranes with 13CF3-Phg PGLa and collection of material for 
unoriented samples by ultracentrifugation, a sample of the supernatant was used for 19F-NMR 
spectroscopy in solution. No signal was observed (spectra not shown). Moreover, 19F-NMR 
spectra of vesicle suspensions did not reveal line shapes characteristic for unoriented 
immobilized (aggregated) peptide. Thus, 13CF3-Phg PGLa can be concluded to be bound to 
the membrane. 
31P-NMR spectra of the presented samples recorded before and after 19F-NMR 
measurements, showed no signs of sample drying. 
Since dipolar splittings obtained from a single PGLa analogue are not enough for a 
full determination of the peptide helix orientation in accordance with the peptide 
amphipathicity, the characteristic line shapes obtained for 13CF3-Phg PGLa from synthetic 
lipid bilayers were used as a fingerprint for a particular alignment.  
6.2.1 13CF3-Phg PGLa in vesicle suspensions of erythrocyte membranes 
As can be seen from Figure 6.1, the NMR line shape at 308 K corresponds to surface aligned 
13CF3-Phg PGLa in vesicles, irrespective of the P/PL ratio (compare line shape to Figure 4.4 
at low P/L ratio from 298 K upwards and to Figure 4.10 at high P/L ratio at 323 K, both 
representing the S-state). Negative dipolar splittings, as extracted from the spectra, 
correspond to 13CF3-Phg PGLa in the S-state, as determined for oriented samples (compare 
to 4.2.2, 4.2.3 and 4.2.5). 
 
 
Figure 6.1 Solid state 
19
F-NMR spectra of 13CF3-Phg PGLa in suspensions of 
erythrocyte ghosts at low (1/300) (upper) and high (1/40) (lower) P/PL ratio at 308 
K. Dipolar splittings are estimated with an accuracy of 0,5 kHz. 
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Figure 6.2 shows the NMR spectra at high P/PL ratio (1/40) as a function of temperature. 
Upon increase in temperature from 278 to 318 K a gradual change in the line shape can be 
observed. Identical numbers of scans for each step in the temperature series allow the 
comparison of signal intensities. At 278 K a sharp isotropic signal dominates the spectrum. Its 
intensity decreases and base broadens gradually upon elevation of temperature, and the 
negative dipolar splitting corresponding to a surface alignment evolves. Due to the collection 
of less scans in the temperature series compared to the spectra recorded at single temperatures 
to avoid drying out of the sample, the signal intensity and the signal-to-noise ratio of spectra 
in Figure 6.2 is lower compared to Figure 6.1. Here, the surface alignment is only well-
pronounced at 318 K. 
 
 
 
Figure 6.2 Solid state 
19
F-NMR spectra of 13CF3-Phg 
PGLa in suspensions of erythrocyte ghosts at high P/PL 
ratio (1/40) at different temperatures. Dipolar splitting at 
318 K is estimated with an accuracy of 0,5 kHz. 
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6.2.2 13CF3-Phg PGLa in vesicle suspensions of Micrococcus luteus 
The 19F-NMR spectrum at high P/PL ratio (1/20) at 308 K (Figure 6.3) does not show signals 
corresponding to aggregated and unoriented peptide. Similar to erythrocyte membranes at 308 
K (Figure 6.1), it exhibits the line shape characteristic for 13CF3-Phg PGLa in a surface 
alignment in vesicles. However, it is comparatively broad and with a slightly larger negative 
dipolar splitting. Compared to erythrocytes, the spectrum is better resolved. 
 
 
Figure 6.3 Solid state 
19
F-NMR spectrum of 13CF3-Phg PGLa in suspensions of M. 
luteus membrane vesicles at high P/PL ratio (1/20) at 308 K. Dipolar splitting is 
estimated with an accuracy of 0,5 kHz. 
 
With increase in temperature from 288 K to 323 K at high P/PL ratio (1/20), a gradual 
significant change of the line shape can be observed (Figure 6.4). At lower temperature the 
signal around the isotropic position is broad. An unresolved signal with a dipolar splitting 
estimated to be larger than -5 kHz at 288 K, distinctly differs from the maximal splitting of an 
unoriented immobilized peptide. Upon increase in temperature, the base of the isotropic 
signal becomes narrower. The size of the negative dipolar splitting decreases, while its triplet 
gradually becomes more pronounced. These might indicate a reorientation between an 
inclined to a surface alignment. At 308 K, the line shape as above can already be identified. 
Upon further elevation of temperature, the dipolar splitting becomes more pronounced and its 
value slightly decreases. 
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Figure 6.4 Solid state 
19
F-NMR spectra of 13CF3-Phg PGLa 
in suspensions of M. luteus membrane vesicles at high P/PL 
ratio (1/20) at different temperatures. Dipolar splitting at 
323 K was estimated with an accuracy of 0,5 kHz. 
 
6.2.3 13CF3-Phg PGLa in oriented erythrocyte membranes 
13CF3-Phg PGLa at high P/PL ratio (1/40) in oriented membranes of erythrocytes at 308 K 
exhibits broad lines with negative dipolar splittings at 0° as well as 90° tilt (Figure 6.5), as 
they are expected for unoriented immobilized peptide. However, as the line shapes are not 
identical, but a slight shift upon tilt and hence membrane-bound and oriented peptide was 
suspected, a temperature series was performed. 
 
 
Figure 6.5 Solid state 
19
F-NMR spectra of 13CF3-Phg PGLa in oriented erythrocyte 
membranes at high P/PL ratio (1/40) at 308 K at 0° (upper) and 90° tilt (lower). 
Dipolar splittings are estimated with an accuracy of 0,5 kHz. 
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19F-NMR spectra at high P/PL ratio (1/40) show a temperature-dependent change of line 
shape in the range from 308 K to 343 K (Figure 6.6). Broad negative dipolar splittings as 
shown in Figure 6.5, expected for unoriented immobilized peptide, persist throughout all 
temperatures. However, at elevated temperature, the evolution of positive dipolar splittings 
corresponding to a surface alignment of 13CF3-Phg PGLa can also be observed (compare e.g. 
Figure 4.3, Figure 4.5). 
 
 
Figure 6.6 Solid state 
19
F-NMR spectra of 13CF3-
Phg PGLa in oriented erythrocyte membranes at 
high P/PL ratio (1/40) at different temperatures. 
The spectra are measured with the membrane normal 
of the oriented sample aligned at 0° tilt with regard to 
the magnetic field. Dipolar splittings at 343 K are 
estimated with an accuracy of 0,5 kHz. 
 
Solid state NMR spectra at lower P/PL ratios, i.e. 1/80, 1/100 and 1/300 at 308 K, exhibited 
comparable line shapes and similar dipolar splittings as those in Figure 6.5. However, due to 
the low amount of peptide, the signal-to-noise ratio of these spectra was poor (data not 
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shown). At elevated temperature for lower P/PL ratios, indications of positive dipolar 
splitting as those at the P/PL ratio of 1/40 (Figure 6.6) were found. A better-resolved 
spectrum at the low P/PL ratio of 1/300 at 308 K was obtained through a measurement with a 
larger number of scans. Due to the long measurement times needed, such experiments could 
not be performed for all temperatures at all P/L ratios. 
 
In addition to a large negative dipolar splitting indicating unoriented immobilized peptide, the 
spectrum at the low P/PL of 1/300 exhibits positive dipolar splitting corresponding to a 
surface alignment of 13CF3-Phg PGLa (Figure 6.7). 
 
 
Figure 6.7 Solid state 
19
F-NMR spectrum of 13CF3-Phg PGLa in oriented erythrocyte 
membranes at low P/PL ratio (1/300) at 308 K. Positive dipolar splitting was estimated 
with an accuracy of 0,5 kHz. 
 
6.2.4 13CF3-Phg PGLa in oriented Micrococcus luteus membranes 
Solid state 19F-NMR spectra of 13CF3-Phg PGLa in oriented membranes of M. luteus at high 
P/PL ratio (1/40) do not show the line shape of unoriented immobilized peptide (Figure 6.8). 
Significantly different line shapes are obtained at 0° and 90° tilt at 308 K as well as at 338 K. 
Thus, the peptide can be concluded to be membrane-bound and oriented to a large extent. 
Signals are broad and not well-resolved. Yet a surface alignment of PGLa is indicated, as 
scaling of signal around the isotropic position upon tilt of sample by 90° at 308 K as well as 
at 338 K can be observed. Additionally, a broad signal with negative dipolar splitting is 
present at 308 K at 0° tilt, but does not scale around the isotropic position upon tilting. This 
broad unresolved component is absent at elevated temperature. At elevated temperature, an 
additional signal shows large negative dipolar splitting at 0° as well as 90° tilt. Similar line 
shapes with a large negative dipolar splitting suggest unoriented immobilized peptide. All 
spectra exhibit an isotropic component largely broadening to the base. 
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Figure 6.8 Solid state 
19
F-NMR spectra of 13CF3-Phg PGLa in oriented membranes of M. luteus at high 
P/L ratio (1/40) at 308 K (left column) and 338 K (right column). The samples are aligned with their 
membrane normals at 0° (upper row) and 90° (lower row) tilt with regard to the magnetic field. 
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6.3 Discussion 
In the present study, an AMP was observed for the first time directly in isolated cell 
membranes of human erythrocytes and the Gram-positive bacterium M. luteus by 19F-solid 
state NMR spectroscopy. 13CF3-Phg PGLa was investigated in vesicle suspensions as well as 
oriented samples of cell membranes to identify the alignment states of the peptide, which so 
far have been found in synthetic model membranes composed of few lipids. An attempt was 
made to identify the principle differences in both types of membranes, and to correlate them 
with the preference of the AMP for bacterial membranes. 
 Previous NMR spectroscopical investigations on AMPs in general and on PGLa in 
particular, restricted themselves to synthetic model membranes or bilayers composed of 
membrane lipid extracts. A previous study employed suspensions of live bacterial cells and 
focused on the behaviour of phospholipids upon application of AMPs (Chia 2000). However, 
as it could be demonstrated in this thesis, various additional sources of phosphorus from 
inside and outside the cell may severely influence 31P-NMR spectra, thus hindering the 
interpretation (5.2). 
Analysis of PGLa structure and alignment in synthetic model membranes (see 4) 
revealed that among the CF3-Phg PGLa analogues, 13CF3-Phg PGLa is the most appropiate 
peptide to apply to cell membranes. It demonstrates the most varied 19F-NMR spectra for the 
three alignment states of the peptide. The solid state 19F-NMR spectra from this peptide, 
measured in oriented samples and multilamellar vesicles, provided the reference set for the 
identification of the S-state, T-state and I-state (see the respective spectra in 4.2 and the 
corresponding discussion in 4.3). 
 
As it can be judged from solid state 31P-NMR spectra, none of the employed samples indicate 
perturbance of the cytoplasmic membranes due to the bound PGLa, in full correspondence to 
the peptide behaviour in synthetic lipid bilayers. 
 
It could be demonstrated that multiple alignments of PGLa coexist in cell membranes of 
erythrocytes as well as of M. luteus. Thus, an unambiguous assignment of the states cannot be 
performed with only one labeled PGLa analogue, as this provides only limited (general) 
information. Yet this result it not surprising, as a similar tendency of multiple simultaneous 
alignments could already be observed for PGLa in the presence of magainin 2 in oriented 
lipid bilayers (4.2.7 and 4.3). Furthermore, in cell membranes, a much higher heterogenity of 
lipid species, as well as large amount and variety of protein components, are expected to exert 
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significant effects in this respect, i.e. by crowding. Another difficulty is the undefinable 
fluidity state of the overall cell membranes. As it was demonstrated in this study, PGLa 
alignment in lipid bilayers is strongly influenced by the phase behaviour. Correspondingly, 
different environments provided in cell membranes simultaneously may exert a severe 
influence on peptide behaviour. 
 
Despite these difficulties, for all employed samples at the physiologically relevant 
temperature around 308 K, a surface alignment can be identified for PGLa. 
The surface alignment is indicated in oriented erythrocyte membranes at the low P/PL 
ratio of 1/300. It is least pronounced at the high P/PL ratio of 1/40, though it is suggested 
upon tilt of sample by 90°, and it can be discriminated upon elevation of temperature. Both 
samples are dominated by a spectral component of unoriented immobilized peptide. 
Correspondingly, the surface alignment can be observed in vesicles, with a dominating 
isotropic signal instead, which is more pronounced at high P/PL ratio. It is thus reasonable to 
assign these obvious additional signals from both types of samples to each other. As solution 
19F-NMR spectroscopy demonstrated that PGLa was not dissolved in the media of vesicles, 
this population of peptide can be assumed to be bound to the membrane or its associated 
structures. The contribution of this population may be larger at higher P/PL ratio in both types 
of samples, as only a limited extent of peptide is accomodated by the lipid environment in a 
surface alignment. It cannot be determined if this residual PGLa is bound to some 
extramembraneous structure mobile in membrane suspension, but with restricted mobility in 
stacked membranes or resides in the lipid environment in a state exhibiting different 
behaviour under the conditions of vesicles and oriented membranes. The participation in the 
surfacial alignment, however, for high P/PL ratio was found to increase upon elevation of 
temperature. 
Contrary to erythrocytes, at the physiologically relevant temperature around 308 K, no 
contribution of unoriented and immobilized peptide at high P/PL ratio to the spectra of 
oriented membranes of M. luteus can be identified. Surfacially aligned PGLa is indicated in 
vesicles and confirmed in oriented membranes upon tilt of sample by 90°. At the same time, 
in oriented membranes a broad negative signal does not scale around the isotropic position. 
The speculation that it may correspond to immobilized and strongly tilted peptide at least is 
not eliminated by vesicle samples. Overall, the extent of this PGLa fraction is found to 
decrease with increasing temperature, in favour of a surfacial alignment. 
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Among the physiologically most relevant systems investigated here, namely cell 
membrane vesicles at around 308 K, no indication for a major contribution of a stably 
inserted alignment can be found. Even beyond that, no clear evidence for this state can be 
identified. Yet it cannot be excluded for minor populations of PGLa, for reasons described 
above. However, the present results rather suggest a transient formation of pores. 
 
Amongst others, the selectivity of natural linear positively charge amphipathic AMPs, 
including PGLa for bacterial over animal cells is attributed to the interaction with the 
negative or zwitterionic lipids of the respective cell membranes. Although there is no simple 
correlation between the peptide charge and the antimicrobial activity of an AMP, the 
reduction or addition of positive charge to a peptide was demonstrated to result in a loss or a 
gain of activity, respectively. These electrostatic interactions are supposed to play a major 
role in the initial attraction and the partitioning of AMPs into lipid bilayers (Dathe 1999). On 
the other hand, the presence of zwitterionic lipids and cholesterol, which are abundant in 
erythrocyte membranes, was demonstrated to contribute to the protection of lipid membranes 
from lysis by magainin 2 and related peptides (Matsuzaki 1995a). It may thus be speculated 
that PGLa may be accomodated to a larger extent by the membranes of M. luteus as compared 
to those of erythrocytes. Possibly, the fraction of peptide found in addition to the surfacially 
aligned PGLa in erythrocyte membranes represents peptide bound to some extracellular 
membrane compount, presumably the glycokalyx, whereas in M. luteus membranes, the 
major part of PGLa resides in the lipid environment. 
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7 Summary 
For PGLa and magainin 2 separately, as well as together as a synergetic pair, toroidal pore 
formation is proposed as an explanation of the permeabilizing activity. Previously, by solid 
state NMR spectroscopy, PGLa was found to realign in synthetic lipid bilayers upon increase 
in peptide concentration from a monomeric flat surface-bound S-state to a tilted T-state, 
presumably forming homodimers. In the presence of equimolar quantity of magainin 2, PGLa 
was shown to adopt a membrane-inserted I-state, compatible with a pore structure. 
In this study, to find out whether the observed alignment states (S, T and I) occur only 
in synthetic lipid bilayers or are relevant in vivo, PGLa alignment was studied by solid state 
NMR in cell membranes. The highly NMR-sensitive, and in biological samples background-
free 19F nucleus in form of a CF3-group was used as a reporter for the peptide orientation. 
Cell membranes from the Gram-positive bacterium Micrococcus luteus and from 
human erythrocytes were prepared by hypotonic lysis followed by extensive washing. After 
incubation of membranes with appropiate amounts of peptide, PGLa orientation was observed 
either in vesicle suspensions after collecting material by centrifugation, or in oriented 
membranes after drying and rehydration on glass support. 
Solid state 31P-NMR spectroscopy of phospholipids served to control the quality of  
the membrane preparations. Spectra showed a typical lamellar lipid phase of vesicles and 
alignment of lipids in oriented samples. The mosaic spread of aligned lipids was attributed to 
the complex lipid composition of cell membranes and high amount of protein. 
Correspondingly, this was larger for M. luteus membranes, containing higher amounts of 
protein compared to erythrocytes. Initial attempts to prepare membranes of B. subtilis 
delivered unsuitable material. Spectra of phospholipids were dominated by some large 
isotropic compound, presumably originating from teichoic acids. These are abundant in the 
envelope of most Gram-positive bacteria, however are luckily absent in M. luteus. 
The complexity of real biomembranes required additional prior investigation of PGLa 
structure and orientation in the presence or absence of magainin 2 in synthetic lipid bilayers 
under different conditions. PGLa could be demonstrated to adopt each alignment state (S, T 
and I) individually, dependent on temperature and lipid bilayer phase. In presence of 
magainin 2, PGLa showed in principle the same temperature-dependent realignment. Yet, its 
behaviour was more complex. In the gel phase, in addition to the I-state, a surface aligned 
fraction of PGLa was found. Furthermore, magainin 2 stabilized a deeper inserted T-state into 
fluid lipid membranes. These results support models that explain permeabilizing activity of 
PGLa and PGLa/magainin 2 as a result of pore formation. Furthermore, the faster formation 
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of more stable transmembrane assemblies, served as an explanation to rationalize the 
enhanced functional activity of the synergetic heterodimer PGLa/magainin 2, may be 
attributed to the observed larger inclination and a presumably deeper immersion of the 
peptides. 
For investigations in cell membranes, the PGLa analogue exhibiting the most 
pronounced difference in spectral appearance between the three alignment states found in 
synthetic model membranes was selected (13CF3-Phg PGLa). 
Hence, for the first time it was possible to observe an antimicrobial peptide directly in 
cell membranes by solid state 19F-NMR spectroscopy. The coexistence of multiple alignment 
states could be demonstrated. This is not surprising, considering the heterogeneous 
composition and complex phase behaviour of real biomembranes. A similar tendency of 
multiple simultaneous alignments as well as a temperature-dependent behaviour could indeed 
be observed in synthetic lipid bilayers. Thus, an unambiguous assigment of all alignment 
states is not possible with one labeled PGLa analogue alone. However, a surface alignment 
could be identified irrespective of peptide concentration. On the contrary, an I-state was not 
indicated. If pore formation occurs in cell membranes, it appears to be a transient event. Yet it 
can be trapped and investigated under conditions of oriented samples. 
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8 Concluding remark and outlook 
In the present study, an AMP was observed for the first time directly in cell membranes by 
solid state 19F-NMR spectroscopy. Coexistence of different alignment states was indicated for 
PGLa in cell membranes of M. luteus and human erythrocytes of complex composition and 
undefined fluidity state. This behaviour was anticipated by preceding studies of PGLa and 
PGLa/magainin 2 on a smaller scale in simple synthetic lipid bilayers. Taken together, 
significant insight was gained not only with regard to a further factor affecting the 
realignment of these peptides, but towards a broader understanding of the activity of AMPs in 
real biomembranes. 
Since the present study demonstrated the principle feasibility to observe AMPs 
directly in real cell membranes, this potential should be tapped in following studies, towards 
the understanding of the structure and orientation of PGLa in vivo. At first, protocols for the 
preparation of cell membranes should be optimized in terms of yield. Then, to overcome the 
overwhelming coexistence of alignment states, a limited range of appropiate experimental 
temperatures may be defined. For that purpose, the accurate determination of cell membrane 
properties is necessary, i.e. establishment of phase diagrams, determination of phase 
transition temperature(s), width(s) of the phase transition(s) or otherwise. For a refinement of 
PGLa structure and orientation in cell membranes, additional analogues need to be employed. 
In a simpler approach, appropiate analogues may be chosen to identify a particular alignment 
and to distinguish between different states, like 13CF3-Phg turned out to be the most 
appropiate one to identify a surface alignment among the others. Enzymatic digestion of 
extramembraneous components may help to differentiate between membrane- and non-
membrane-bound fractions of peptide. Magainin 2 was already employed on bacterial 
membranes in initial experiments of this study. Yet due to lack of references then, results 
were ambiguous. With the results presented here, the implications are promising and 
systematic studies should be performed likewise. 
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9 Zusammenfassung 
Für die membranpermeabilisierenden Eigenschaften der Peptide PGLa und Magainin 2, sowohl 
einzeln wie auch als synergetisches Paar, wird die Bildung einer toroidalen Pore angenommen. Mittels 
Festkörper-NMR-Spektroskopie konnte für PGLa an synthetischen Modellmembranen mit steigender 
Peptidkonzentration die Umorientierung von einem peripher gebundenen Zustand (S-state) zu einer 
schrägen Ausrichtung (T-state) gezeigt werden. In Anwesenheit von Magainin 2 wurde ein tief 
eingesenkter Zustand (I-state) entdeckt, welcher mit einer vorgeschlagenen Pore vereinbar wäre. 
In dieser Studie wurde PGLa in Zellmembranen untersucht, um die Relevanz der beobachteten 
Orientierungen (S-,T- und I-state) für biologische Systeme zu prüfen. Mittels 19F-NMR-Spektroskopie 
wurde die Orientierung des CF3-markierten PGLa beobachtet. 
Membranen des Gram-positiven Bakteriums Micrococcus luteus und menschlicher 
Erythrozyten wurden mittels hypotoner Lyse und ausgiebigem Waschen gewonnen und mit Peptid 
inkubiert. Die Ausrichtung des PGLa wurde in Membranvesikelsuspension und in orientierten 
Membranen beobachtet. 
 31P-NMR-Spektroskopie an den Phospholipiden diente der Kontrolle der Präparatequalität und 
zeigte eine typische lamellare Lipidphase in Vesikeln und Ausrichtung der Lipide in orientierten 
Proben. Die Spreizung der Lipidsignale orientierter Proben wurde auf die komplexe 
Zusammensetzung und den hohen Proteingehalt der Zellmembranen zurückgeführt. Sie war 
erwartungsgemäss größer für Membranen von M. luteus, welche im Vergleich zu Erythrozyten 
erheblich mehr Protein enthalten. Anfängliche Membranpräparationen an B. subtilis lieferten kein 
geeignetes Material. Die 31P-Spektren wurden von einem isotropen Signal beherrschte, welches 
vermutlich auf Teichonsäuren zurückzuführen ist. Diese sind üblicherweise in Gram-positive 
Bakterien vorhanden, wobei M. luteus eine Ausnahme darstellt. 
 Die Komplexität biologischer Membranen machte vorbereitende eingehendere 
Untersuchungen an PGLa mit und ohne Magainin 2 an synthetischen Lipidmembranen notwendig. In 
beiden Fällen konnte für PGLa eine Umorientierung in Abhängigkeit von Temperatur und Lipidphase 
gezeigt werden. Im Gelzustand der Lipidmembranen nahm PGLa einen I-Zustand an. In Anwesenheit 
von Magainin 2 konnte eine zusätzliche Peptidfraktion in einer peripheren Bindung gefunden werden. 
In der flüssigkristallinen Phase lag in beiden Fällen eine schräge Orientierung vor, welche jedoch bei 
Anwesenheit von Magainin 2 eine deutlich stärkere Neigung aufwies. Diese Ergebnisse stützen die 
Annahmen, dass die Permeabilisierung von Membranen durch PGLa und PGLa/Magainin 2 auf 
Porenbildung beruht. Als Erklärung für die synergetische Wirkung von PGLa/Magainin 2 wird eine 
schnellere Bildung langlebigerer Poren diskutiert. Dieses Verhalten könnte mit dem hier beobachteten 
stärkeren Neigungswinkel, welcher zu einem tieferen Einsenken der Peptide in die Lipidmembran 
führen sollte, teilweise erklärt werden. 
 Jenes PGLa Analogon, dessen 19F-NMR-Spektren der drei Zustände (S, T und I) sich am 
stärksten unterschieden (13CF3-Phg PGLa), wurde für weitere Untersuchungen an Zellmembranen 
herangezogen. 
 Somit konnte das erste Mal ein antimikrobielles Peptid mittels Festkörper-NMR-
Spektroskopie am hochempfindlichen 19F-Kern in biologischen Membranen beobachtet werden. Es 
konnte die gleichzeitige Anwesenheit unterschiedlicher Ausrichtungen des PGLa gezeigt werden. Dies 
ist insofern nicht überraschend, da Zellmembranen sehr komplex aufgebaut sind und nur ein wenig 
definiertes Phasenverhalten aufweisen. Bereits in Membranen synthetischer Lipide wurden tatsächlich 
zwei Zustände gleichzeitig gefunden. Zudem konnte gezeigt werden, dass das Verhalten des PGLa 
von der Lipidphase abhängt. Eine zweifelsfreie Zuordnung aller Ausrichtungen in Zellmembranen ist 
somit mit einem einzigen Analogon nicht möglich. Allerdings konnte eine periphere Bindung des 
PGLa an Zellmembranen identifiziert werden. Im Gegensatz dazu fand sich jedoch kein Hinweis auf 
eine Insertierung des PGLa entsprechend einer Pore. Sollte Porenbildung in Zellmembranen 
stattfinden, muss es sich um ein vorübergehendes Ereignis handeln. Dieses kann in orientierten 
Lipidmembranen festgehalten und untersucht werden. 
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11 Appendices 
11.1 List of abbreviations 
AMP antimicrobial peptide 
CF3-Phg L-4-trifluoromethyl-phenylglycine 
CSA chemical shift anisotropy 
DMDG dimannosyldiacylglycerol 
DMPC dimyristoylphosphatidylcholine 
DMPG dimyristoylphosphatidylglycerol 
DPG diphosphatidylglycerol 
dw dry weight 
FID free induction decay 
GPI glycosyl-phosphatidylinositol 
LPS lipopolysacccharide 
LTA lipoteichoic acids 
Mag 2 magainin 2 
NMR nuclear magnetic resonance 
PAS principal axes system 
PC phosphatidylcholine 
PE phosphatidylethanolamine 
PG phosphatidylglycerol 
PGLa peptidyl-glycine-leucine-carboxyamide 
Phg phenylglycine 
PI phosphatidylinositol 
P/L peptide to lipid (ratio) 
P/PL peptide to phospholipid (ratio) 
PS phosphatidylserine 
RF radio frequency 
RMSD root mean square deviation 
SDH succinic acid dehydrogenase 
SM sphingomyelin 
TA teichoic acids 
v/v volume by volume 
v/w volume by weight 
wt wild type 
WTA wall teichoic acids 
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